WO2009102393A1 - Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device - Google Patents
Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device Download PDFInfo
- Publication number
- WO2009102393A1 WO2009102393A1 PCT/US2009/000386 US2009000386W WO2009102393A1 WO 2009102393 A1 WO2009102393 A1 WO 2009102393A1 US 2009000386 W US2009000386 W US 2009000386W WO 2009102393 A1 WO2009102393 A1 WO 2009102393A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrical signal
- electrode
- electrodes
- configuration
- anode
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
Definitions
- This invention relates generally to medical devices, and, more particularly, to methods, apparatus, and systems for providing improved charge utilization when providing an electrical signal therapy by a medical device.
- the endogenous electrical activity (Le., activity attributable to the natural functioning of the patient's own body) of a neural structure of a patient may be modulated in a variety of ways.
- the electrical activity may be modulated by exogenously applied (i.e., from a source other than the patient's own body) electrical, chemical, or mechanical signals applied to the neural structure.
- the modulation (hereinafter referred to generally as “neurostimulation” or “neuromodulation”) may involve the induction of afferent action potentials, efferent action potentials, or both, in the neural structure, and may also involve blocking or interrupting the transmission of endogenous electrical activity traveling along the nerve.
- Electrical signal therapy or electrical modulation of a neural structure refers to the application of an exogenous therapeutic electrical signal (as opposed to a chemical or mechanical signal), to the neural structure.
- Electrical signal therapy may be provided by implanting an electrical device underneath the skin of a patient and delivering an electrical signal to a nerve such as a cranial nerve.
- the electrical signal therapy may involve performing a detection step, with the electrical signal being delivered in response to a detected body parameter. This type of stimulation is generally referred to as “active,” “feedback,” or “triggered” stimulation.
- the system may operate without a detection system once the patient has been diagnosed with epilepsy (or another medical condition), and may periodically apply a series of electrical pulses to the nerve (e.g., a cranial nerve such as a vagus nerve) intermittently throughout the day, or over another predetermined time interval.
- This type of stimulation is generally referred to as "passive,” “non-feedback,” or “prophylactic,” stimulation.
- the stimulation may be applied by an implantable medical device that is implanted within the patient's body.
- a number of medical conditions that are amenable to electrical signal therapy via cranial nerve stimulation present symptoms in regions outside the brain. For example, disorders of the neurological system, the gastrointestinal system, the pancreas, or the kidneys, feature impaired or improper function of those organs. Diabetes, particularly type I diabetes, often features impaired production of insulin by the islets of Langerhans in the pancreas. Electrical signal stimulation of either the brain alone or the organ alone may have some efficacy in treating such medical conditions, but may not have maximal eff
- the present invention relates to a method of treating a medical condition in a patient using an implantable medical device.
- a first electrode is coupled to a first portion of a cranial nerve of the patient.
- a second electrode is coupled to a second portion of the cranial nerve of the patient.
- a first electrical pulse is provided to the first and second electrodes.
- the first electrical pulse is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode.
- the anode and cathode each comprises an accumulated energy.
- a second electrical pulse is provided to the first and second electrodes.
- the second electrical pulse comprises at least a portion of the accumulated energy.
- the present invention relates to another method for treating a medical condition in a patient using an implantable medical device.
- a first electrical signal is provided to a first electrode coupled to a first portion of a cranial nerve of the patient, as well as to a second electrode coupled to a second portion of a cranial nerve of the patient.
- the first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode.
- the anode and cathode each comprises an accumulated energy based upon the first signal pulse.
- a second configuration of the electrodes is provided upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode function as the anode.
- a second electrical signal is provided to the first and second electrodes in the second configuration.
- the second electrical signal comprises at least a portion of the accumulated energy.
- the present invention relates to another method for treating a medical condition in a patient using an implantable medical device.
- a first electrode is coupled to a portion of a right cranial nerve of the patient.
- a second electrode is coupled to a portion of a left cranial nerve of the patient.
- a first electrical signal is provided to the first and second electrodes.
- the first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode.
- the anode and cathode each comprise an accumulated energy.
- a second configuration of the electrodes is provided upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode function as the anode.
- a second electrical signal is provided to the first and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy.
- the present invention relates to an implantable medical device for treating a medical condition in a patient.
- the device includes a controller capable of receiving data and controlling the operation of the implantable medical device by providing at least one control parameter.
- the device also includes a stimulation unit for generating and delivering, based upon the at least one control parameter, a first electrical signal to a first electrode electrically coupled to a first portion of a cranial nerve and to a second electrode electrically coupled to a second cranial nerve.
- the first electrical signal is provided in a first configuration, in which the first electrode functions as an anode and the second electrode functions as a cathode.
- the anode and cathode each includes an accumulated energy resulting from the first electrical signal.
- the device also comprises an electrode polarity reversal unit that is capable of changing the configuration of the first and second electrodes from the first configuration to the second configuration.
- the stimulation unit also generates and delivers a second electrical signal to the first and second electrodes in the second configuration.
- the second electrical signal comprises at least a portion of the accumulated energy.
- the present invention relates to a computer readable program storage device encoded with instructions that, when executed by a computer, performs a method for treating a medical condition in a patient. The method includes providing a first electrical signal to a first electrode coupled to a first portion of a cranial nerve of the patient, and to a second electrode coupled to a second portion of a cranial nerve of the patient.
- the first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode.
- the anode and cathode each includes an accumulated energy.
- the method also includes providing a second configuration of the electrodes upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode functions as the anode.
- a second electrical signal is provided to the first and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy.
- Figures 1A-1C provide stylized diagrams of an implantable medical device implanted into a patient's body for providing electrical signals to a portion of the patient's body, in accordance with one illustrative embodiment of the present invention
- Figure 2 illustrates a block diagram depiction of the implantable medical device of
- FIG. 3 illustrates a block diagram depiction of an electrode polarity reversal unit shown in Figure 2, in accordance with one illustrative embodiment of the present invention
- Figure 4 illustrates a flowchart depiction of a method for performing limited patient- initiated electrical signal therapy, in accordance with an illustrative embodiment of the present invention
- Figure 5 illustrates a flowchart depiction of a method for performing limited patient- initiated electrical signal therapy, in accordance with another illustrative embodiment of the present invention
- Figure 6 illustrates an implementation of the IMD of Figure 2 and related electrodes in an illustrative configuration, in accordance with one illustrative embodiment of the present invention
- Figures 7A-7D provide various diagrams illustrating electrical characteristics of signals generated by the IMD 200 in the configuration provided in Figure 6;
- Figure 8 illustrates a reversed configuration of the IMD relative to the configuration illustrated in Figure 6, in accordance with one illustrative embodiment of the present invention
- Figures 9A-9D provide various diagrams illustrating electrical characteristics of signals generated by the IMD 200 in the configuration provided in Figure 8;
- Figures 10A- 1OD provide various electrical diagrams of signals at various nodes of the configuration illustrated in Figures 6 and 8, in accordance with one illustrative embodiment of the present invention.
- Coupled or “couples” is intended to mean either a direct or an indirect electrical .connection.
- Direct contact indicates that a surface of a first element contacts the surface of a second element with no substantial attenuating medium there between.
- the presence of small quantities of substances, such as bodily fluids, that do not substantially attenuate electrical connections does not vitiate direct contact.
- the word “or” is used in the inclusive sense (i.e., “and/or") unless a specific use to the contrary is explicitly stated.
- electrode or “electrodes” described herein may refer to one or more stimulation electrodes (i.e., electrodes for delivering an electrical signal generated by an IMD to a tissue), sensing electrodes (i.e., electrodes for sensing a physiological indication of a patient's body), and/or electrodes that are capable of delivering a stimulation signal, as well as performing a sensing function.
- stimulation electrodes i.e., electrodes for delivering an electrical signal generated by an IMD to a tissue
- sensing electrodes i.e., electrodes for sensing a physiological indication of a patient's body
- electrodes that are capable of delivering a stimulation signal, as well as performing a sensing function.
- VNS vagus nerve stimulation
- a number of medical conditions pertaining to or mediated by one or more structures of the nervous system of the body including epilepsy and other movement disorders, depression, anxiety disorders and other neuropsychiatric disorders, dementia, head trauma, coma, migraine headache, obesity, eating disorders, sleep disorders, cardiac disorders (such as congestive heart failure and atrial fibrillation), hypertension, endocrine disorders (such as diabetes and hypoglycemia), and pain, among others. See, e.g., U.S. Pats. Nos.
- the present invention provides a method of treating a medical condition.
- the medical condition can be selected from the group consisting of epilepsy, neuropsychiatric disorders (including but not limited to depression), eating disorders/obesity, traumatic brain injury/coma, addiction disorders, dementia, sleep disorders, pain, migraine, endocrine/pancreatic disorders (including but not limited to diabetes), motility disorders, hypertension, congestive heart failure/cardiac capillary growth, hearing disorders, angina, syncope, vocal cord disorders, thyroid disorders, pulmonary disorders, gastrointestinal disorders, kidney disorders, and reproductive endocrine disorders (including infertility).
- the medical condition is selected from the group consisting of depression, epilepsy, obesity, bulimia, traumatic brain injury, congestive heart failure, stroke, coma, fibromyalgia, addiction disorders, multiple sclerosis, haring disorder,
- Alzheimer's disease Parkinson's disease, gastrointestinal disorders, pancreatic disorders, kidney disorders, and diabetes.
- embodiments of the present invention provide for performing a bipolar stimulation utilizing a node reversal technique.
- the bipolar stimulation may be implemented in a bilateral and/or a unilateral fashion, e.g., in vagus nerve stimuation, to both the left and right branches of the vagus nerve (bilateral stimulation), or to the left vagus nerve alone or the right vagus nerve alone (unilateral stimulation).
- a bilateral and/or a unilateral fashion e.g., in vagus nerve stimuation, to both the left and right branches of the vagus nerve (bilateral stimulation), or to the left vagus nerve alone or the right vagus nerve alone (unilateral stimulation).
- efficiency in charge usage may be realized.
- Embodiments of the present invention provide for utilizing the excess charges resulting from delivery of a previously applied therapeutic electrical signal.
- the excess charges may be used in a manner whereupon reversal of electrical nodes of electrodes associated with an IMD may be used to boost a subsequently generated and applied electrical signal, thereby realizing improved efficiencies and charge usage. Utilizing techniques provided by the present invention, increase of charge efficiency resulting in decrease of charge usage in the order of 80% or above may be realized.
- Figures IA- 1C depict a stylized implantable medical system 100 for implementing one or more embodiments of the present invention.
- IA- 1C illustrate an electrical signal generator 110 having main body 112 comprising a case or shell 121 ( Figure IB) with a header 116 (Figure IA, IB) for connecting to leads 122.
- the generator 110 is implanted in the patient's chest in a pocket or cavity formed by the implanting surgeon just below the skin (indicated by a line 145, Figure IA), similar to the implantation procedure for a pacemaker pulse generator.
- a stimulating nerve electrode assembly 125 preferably comprising at least an electrode pair, is conductively connected to the distal end of an insulated, electrically conductive lead assembly 122, which preferably comprises a pair of lead wires (one wire for each electrode of an electrode pair).
- Lead assembly 122 is attached at its proximal end to connectors on the header 116 ( Figure IB) on case 121.
- the electrode assembly 125 may be surgically coupled to a cranial nerve, such as vagus nerve 127, in the patient's neck or head, or at another location, e.g., near the patient's diaphragm.
- Other cranial nerves such as the trigeminal and/or glossopharyngeal nerves, may also be used to deliver the therapeutic electrical signal.
- the electrode assembly 125 preferably comprises a bipolar stimulating electrode pair 125-1, 125-2 ( Figure 1C), such as the electrode pair described in U.S. Pat. No. 4,573,481 issued March 4, 1986 to Bullara. Suitable electrode assemblies are available from Cyberonics, Inc., Houston, Texas, USA as the Model 302 electrode assembly. However, persons of skill in the art will appreciate that many electrode designs could be used in the present invention, including unipolar electrodes.
- the two electrodes are preferably wrapped about the cranial nerve, such as vagus nerve 127, and the electrode assembly 125 may be secured to the nerve by a spiral anchoring tether 128 ( Figure 1C) such as that disclosed in U.S. Pat. No.
- Electrode assembly 122 is secured, while retaining the ability to flex with movement of the chest and neck, by a suture connection 130 to nearby tissue ( Figure 1C).
- the open helical design of the electrode assembly 125 (described in detail in the above-cited Bullara patent), which is self-sizing and flexible, minimizes mechanical trauma to the nerve and allows body fluid interchange with the nerve.
- the electrode assembly 125 preferably conforms to the shape of the nerve, providing a low stimulation threshold by allowing a large stimulation contact area with the nerve.
- the electrode assembly 125 comprises two electrode ribbons (not shown), of a conductive material such as platinum, iridium, platinum-iridium alloys, and/or oxides of the foregoing.
- the electrode ribbons are individually bonded to an inside surface of an elastomeric body portion of the two spiral electrodes 125-1 and 125-2 ( Figure 1C), which may comprise two spiral loops of a three-loop helical assembly.
- the lead assembly 122 may comprise two distinct lead wires or a coaxial cable whose two conductive elements are respectively coupled to one of the conductive electrode ribbons.
- One suitable method of coupling the lead wires or cable to the electrodes 125-1, 125-2 comprises a spacer assembly such as that disclosed in US 5,531,778, although other known coupling techniques may be used.
- each loop is preferably composed of silicone rubber, and the third loop 128 (which typically has no electrode) acts as the anchoring tether for the electrode assembly 125.
- a first electrode is coupled to a first portion of a first electrically- stimulatable structure of the patient, and a second electrode is coupled to a second portion of a second electrically-stimulatable structure of the patient.
- the person of ordinary skill in the art can, in light of the present disclosure, identify electrically-stimulatable structures of the patient as a matter of routine experimentation. By coupling the electrodes as described in this paragraph, electrical signal stimulation can be effected on any electrically-stimulatable structure of the patient.
- the first electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart
- the second electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart.
- the pulse generator case 121 can function as an electrode.
- one or more electrodes 125 can be coupled to a cranial nerve, such as the vagus nerve 127, for delivery of electrical signals to the cranial nerve, and the pulse generator case 121 can be located in proximity to a tissue for delivery of electrical signals to the tissue.
- the electrical pulse generator 110 may be programmed with an external computer 150 using programming software of a type known in the art for stimulating neural structures, or other suitable software based on the description herein, and a programming wand 155 to facilitate radio frequency (RF) communication between the computer 150 ( Figure IA) and the pulse generator 110.
- the wand 155 and software permit wireless, non-invasive communication with the generator 110 after the latter is implanted.
- the wand 155 is preferably powered by internal batteries, and provided with a "power on" light to indicate sufficient power for communication. Another indicator light may be provided to show that data transmission is occurring between the wand and the generator.
- a variety of stimulation therapies may be provided in implantable medical systems 100 of the present invention.
- Different types of nerve fibers e.g., A, B, and C-fibers being different fibers targeted for stimulation
- the different types of nerve fibers have different conduction velocities and stimulation thresholds and, therefore, differ in their responsiveness to stimulation.
- Certain pulses of an electrical stimulation signal may be below the stimulation threshold for a particular fiber and, therefore, may generate no action potential in the fiber.
- smaller or narrower pulses may be used to avoid stimulation of certain nerve fibers (such as C-fibers) and target other nerve fibers (such as A and/or B fibers, which generally have lower stimulation thresholds and higher conduction velocities than C-fibers).
- ⁇ may be employed wherein particular nerve regions may be polarized before a more robust stimulation is delivered, which may better accommodate particular electrode materials.
- opposing polarity phases separated by a zero current phase may be used to excite particular axons or postpone nerve fatigue during long term stimulation.
- the terms “stimulating” and “stimulator” may generally refer to delivery of a signal, stimulus, or impulse to neural tissue for affecting neuronal activity of a neural tissue (e.g., a volume of neural tissue in the brain or a nerve).
- a neural tissue e.g., a volume of neural tissue in the brain or a nerve.
- the effect of such stimulation on neuronal activity is termed “modulation”; however, for simplicity, the terms “stimulating” and “modulating”, and variants thereof, are sometimes used interchangeably herein.
- the effect of delivery of the stimulation signal to the neural tissue may be excitatory or inhibitory and may potentiate acute and/or long-term changes in neuronal activity.
- the effect of "stimulating" or “modulating” a neural tissue may comprise one or more of the following effects: (a) changes in neural tissue to initiate an action potential (bi- directional or uni-directional); (b) inhibition of conduction of action potentials (endogenous or externally stimulated) or blocking the conduction of action potentials (hyperpolarizing or collision blocking), (c) affecting changes in neurotransmitter/neuromodulator release or uptake, and (d) changes in neuro-plasticity or neurogenesis of brain tissue.
- Applying an electrical signal to an autonomic nerve may comprise generating a response that includes an afferent action potential, an efferent action potential, an afferent hyperpolarization, an efferent hyperpolarization, an afferent sub-threshold depolarization, and/or an efferent subthreshold depolarization.
- the stimulation method includes the steps of generating a first electrical signal with the electrical signal generator, applying the first electrical signal to the electrodes, wherein the first electrode is a cathode and the second electrode is an anode, reversing the polarity of the first electrode and the second electrode, yielding a configuration wherein the first electrode is an anode and the second electrode is a cathode, generating a second electrical signal with the electrical signal generator, applying the second electrical signal to the electrodes, reversing the polarity of the first electrode and the second electrode, yielding a configuration wherein the first electrode is a cathode and the second electrode is an anode, generating a third electrical signal with the electrical signal generator, and applying the third electrical signal to the electrodes.
- the first electrical signal, the second electrical signal, and the third electrical signal are substantially identical.
- the first electrical signal may vary from the second electrical signal, the third electrical signal, or both in terms of one or more of pulse width, number of pulses, amplitude, frequency, stimulation on-time, and stimulation off- time, among other parameters.
- the first electrical signal, the second electrical signal, and the third electrical signal are described herein in terms of exemplary illustrations.
- the person of ordinary skill in the art having benefit of the present disclosure would appreciate that more than three electrical signals, up to an nth electrical signal, can be used and are within the scope of the present invention.
- Cathode and “anode” have their standard meanings, as the electrode at which current leaves the IMD system and the electrode at which current enters the IMD system, respectively. Reversing the polarity of the electrodes can be effected by any switching technique known in the art.
- a “pulse” is used herein to refer to a single application of electrical charge from the cathode to the cranial nerve.
- interpulse interval Individual pulses are separated by a time period in which no charge is delivered to the nerve, which can be called the “interpulse interval.”
- a “burst” is used herein to refer to a plurality of pulses, wherein no charge is delivered to the nerve before the first pulse of the burst for a time period at least twice as long as the interpulse interval and no charge is delivered to the nerve after the last pulse of the burst for a time period at least twice as long as the interpulse interval.
- the time period between the end of the last pulse of a first burst and the initiation of the first pulse of the next subsequent burst can be called the "interburst interval.”
- the interburst interval is at least 100 msec.
- a plurality of pulses can refer to any of (a) a number of consecutive pulses within a burst, (b) all the pulses of a burst, or (c) a number of consecutive pulses including the final pulse of a first burst and the first pulse of the next subsequent burst.
- Each of the first, second, and third electrical signals can independently contain one or more pulses.
- the first electrical signal contains one or more pulses
- the second electrical signal contains one or more pulses
- the third electrical signal contains one or more pulses.
- the first electrical signal contains one pulse
- the second electrical signal contains one pulse
- the third electrical signal contains one pulse.
- the number of pulses contained within the first and second electrical signals or the second and third electrical signals need not be equal, and can be in any ratio. In one embodiment, the ratio is from about 1:100 to about 100:1. In a further embodiment, the ratio is from about 1 : 10 to about 10:1.
- the first electrical signal contains a first number of pulses
- the second electrical signal contains a second number of pulses
- the third electrical signal contains a third number of pulses, wherein the first number of pulses is not equal to the second number of pulses or the second number of pulses is not equal to the third number of pulses.
- the first electrical signal contains one or more bursts
- the second electrical signal contains one or more bursts
- the third electrical signal contains one or more bursts.
- the first electrical signal contains one burst
- the second electrical signal contains one burst
- the third electrical signal contains one burst.
- the number of bursts contained within the first and second electrical signals or the second and third electrical signals need not be equal, and can be in any ratio. In one embodiment, the ratio is from about 1:100 to about 100:1. In a further embodiment, the ratio is from about 1:10 to about 10:1.
- the first electrical signal contains a first number of bursts
- the second electrical signal contains a second number of bursts
- the third electrical signal contains a third number of bursts, wherein the first number of bursts is not equal to the second number of bursts or the second number of bursts is not equal to the third number of bursts.
- Typical cranial nerve stimulation can be performed with an interpulse frequency of 20-30 Hz (resulting in a number of pulses per burst of 140-1800, at a burst duration from 7- 60 sec).
- at least one of the first electrical signal, the second electrical signal, and the third electrical signal delivers microbursts.
- Microburst neurostimulation is discussed by US 11/693,451, filed March 2, 2007 and published as United States patent Publication No. 20070233193, and incorporated herein by reference.
- At least one of the first electrical signal, the second electrical signal, and the third electrical signal is characterized by having a number of pulses per microburst from 2 pulses to about 25 pulses, an interpulse interval of about 2 msec to about 50 msec, an interburst period of at least 100 msec, and a microburst duration of less than about 1 sec.
- the subsequent applying step is performed after an action potential induced by the prior applying step in A-fibers of the cranial nerve has passed the anode of the subsequent applying step and before an action potential induced by the prior applying step in C-fibers of the cranial nerve reaches the anode of the subsequent applying step.
- an action potential induced in the A-fibers in the prior applying step can propagate along the nerve in the direction from the cathode of the prior applying step to the anode of the prior applying step and beyond to the brain or the distal terminus of the cranial nerve.
- an action potential induced in the C-fibers in the prior applying step though originally propagating along the nerve in the direction from the cathode of the prior applying step to the anode of the prior applying step, can be blocked by an electrical stimulation performed at the anode of the subsequent applying step, which was the cathode of the prior applying step.
- an electrical stimulation performed at the anode of the subsequent applying step which was the cathode of the prior applying step.
- particular fiber types in the cranial nerve can be selectively stimulated to propagate an action potential to either the proximal terminus (i.e., the brain) or distal terminus of the cranial nerve.
- the IMD 200 may be coupled to various leads, e.g., 122 ( Figures IA, 1C). Stimulation signals used for therapy may be transmitted from the IMD 200 to target areas of the patient's body, specifically to various electrodes associated with the leads 122. Stimulation signals from the IMD 200 may be transmitted via the leads 122 to stimulation electrodes (electrodes that apply the therapeutic electrical signal to the target tissue) associated with the electrode assembly 125, e.g., 125-1, 125-2 ( Figure IA). Further, signals from sensor electrodes (electrodes that are used to sense one or more body parameters such as temperature, heart rate, brain activity, etc.) may also traverse the leads back to the IMD 200.
- stimulation electrodes electrodes that apply the therapeutic electrical signal to the target tissue
- the electrode assembly 125 e.g., 125-1, 125-2
- signals from sensor electrodes may also traverse the leads back to the IMD 200.
- the IMD 200 may comprise a controller 210 capable of controlling various aspects of the operation of the IMD 200.
- the controller 210 is capable of receiving internal data and/or external data and controlling the generation and delivery of a stimulation signal to target tissues of the patient's body.
- the controller 210 may receive manual instructions from an operator externally, or may perform stimulation based on internal calculations and programming.
- the controller 210 is capable of affecting substantially all functions of the IMD 200.
- the controller 210 may comprise various components, such as a processor 215, a memory 217, etc.
- the processor 215 may comprise one or more micro controllers, micro processors, etc., that are capable of executing a variety of software components.
- the memory 217 may comprise various memory portions, where a number of types of data (e.g., internal data, external data instructions, software codes, status data, diagnostic data, etc.) may be stored.
- the memory 217 may store various tables or other database content that could be used by the IMD 200 to implement the override of normal operations.
- the memory 217 may comprise random access memory (RAM) dynamic random access memory (DRAM), electrically erasable programmable read-only memory (EEPROM), flash memory, etc.
- the IMD 200 may also comprise a stimulation unit 220.
- the stimulation unit 220 is capable of generating and delivering a variety of electrical signal therapy signals to one or more electrodes via leads.
- the stimulation unit 220 is capable of delivering a programmed, primary mode electrical signal to the leads 122 coupled to the IMD 200.
- the electrical signal may be delivered to the leads 122 by the stimulation unit 220 based upon instructions from the controller 210.
- the stimulation unit 220 may comprise various types of circuitry, such as stimulation signal generators, impedance control circuitry to control the impedance "seen" by the leads, and other circuitry that receives instructions relating to the type of stimulation to be performed.
- the IMD 200 may also comprise an electrode polarity reversal unit 280.
- the electrode polarity reversal unit 280 is capable of reversing the polarity of electrodes associated with the electrode assembly 125.
- the electrode polarity reversal unit 280 is shown in more detail in Figure 3.
- the electrode polarity reversal unit is capable of reversing electrode polarity rapidly, i.e., in about 10 microseconds or less, and in any event at a sufficiently rapid rate to permit electrode polarities to be changed between adjacent pulses in a pulsed electrical signal.
- the IMD 200 may also comprise a power supply 230.
- the power supply 230 may comprise a battery, voltage regulators, capacitors, etc., to provide power for the operation of the IMD 200, including delivering the stimulation signal.
- the power supply 230 comprises a power-source battery that in some embodiments may be rechargeable. In other embodiments, a non-rechargeable battery may be used.
- the power supply 230 provides power for the operation of the IMD 200, including electronic operations and the stimulation function.
- the power supply 230 may comprise a lithium/thionyl chloride cell or a lithium/carbon monofluoride (LiCFx) cell. Other battery types known in the art of implantable medical devices may also be used.
- the IMD 200 also comprises a communication unit 260 capable of facilitating communications between the IMD 200 and various devices.
- the communication unit 260 is capable of providing transmission and reception of electronic signals to and from an external unit 270.
- the external unit 270 may be a device that is capable of programming various modules and stimulation parameters of the IMD 200.
- the external unit 270 comprises a computer system that is capable of executing a data- acquisition program.
- the external unit 270 may be controlled by a healthcare provider, such as a physician, at a base station in, for example, a doctor's office.
- the external unit 270 may be a computer, preferably a handheld computer or PDA, but may alternatively comprise any other device that is capable of electronic communications and programming.
- the external unit 270 may download various parameters and program software into the IMD 200 for programming the operation of the implantable device.
- the external unit 270 may also receive and upload various status conditions and other data from the IMD 200.
- the communication unit 260 may be hardware, software, firmware, and/or any combination thereof. Communications between the external unit 270 and the communication unit 260 may occur via a wireless or other type of communication, illustrated generally by line 275 in Figure 2.
- the communication unit 260 can transmit a log of stimulation data to the patient, a physician, or another party.
- the LVID 200 is capable of delivering stimulation that can be intermittent, periodic, random, sequential, coded, and/or patterned.
- the stimulation signals may comprise an electrical stimulation frequency of approximately 0.1 to 2500 Hz.
- the stimulation signals may comprise a pulse width in the range of approximately 1 - 2000 micro-seconds.
- the stimulation signals may comprise current amplitude in the range of approximately 0.1 mA to 10 mA.
- the stimulation delivered by the IMD 200 according to its programming may be referred to herein as "normal operations" or as a "normal operating mode.”
- the EMD 200 may also comprise a magnetic field detection unit 290.
- the magnetic field detection unit 290 is capable of detecting magnetic and/or electromagnetic fields of a predetermined magnitude. Whether the magnetic field results from a magnet placed proximate to the IMD 200, or whether it results from a substantial magnetic field encompassing an area, the magnetic field detection unit 290 is capable of informing the IMD of the existence of a magnetic field.
- the changeable electrode polarity stimulation described herein may be activated, deactivated, or alternatively activated or deactivated using a magnetic input.
- the magnetic field detection unit 290 may comprise various sensors, such as a Reed Switch circuitry, a Hall Effect sensor circuitry, and/or the like.
- the magnetic field detection unit 290 may also comprise various registers and/or data transceiver circuits that are capable of sending signals that are indicative of various magnetic fields, the time period of such fields, etc. In this manner, the magnetic field detection unit 290 is capable of detecting whether the detected magnetic field relates to an inhibitory input or an excitory input from an external source.
- the inhibitory input may refer to an inhibition of, or a deviation from, normal stimulation operation.
- the excitory input may refer to additional stimulation or deviation from normal stimulation.
- One or more of the blocks illustrated in the block diagram of the IMD 200 in Figure 2 may comprise hardware units, software units, firmware units, or any combination thereof. Additionally, one or more blocks illustrated in Figure 2 may be combined with other blocks, which may represent circuit hardware units, software algorithms, etc. Additionally, one or more of the circuitry and/or software units associated with the various blocks illustrated in Figure 2 may be combined into a programmable device, such as a field programmable gate array, an ASIC device, etc.
- FIG 3 shows in greater detail the electrode polarity reversal unit 280 ( Figure 2).
- the electrode polarity reversal unit 280 comprises an electrode configuration switching unit 340, which includes a switching controller 345.
- the switching controller 345 transmits signals to one or more switches, generically, n switches 330(1), 330(2), ... 330(n) which effect the switching of the configuration of two or more electrodes, generically, n electrodes 125(1), 125(2), ... ⁇ 25(n).
- Figure 3 shows equal numbers of switches 330 and electrodes 125, the person of ordinary skill in the art having the benefit of the present disclosure will understand that the number of switches 330 and their connections with the various electrodes 125 can be varied as a matter of routine optimization.
- a switching timing unit 333 can signal to the electrode configuration switching unit 340 that a desired time for switching the electrode configuration has been reached.
- a first stimulation regimen may call for a particular type of pulse signal in one direction and having one electrode polarity configuration ⁇ e.g., an electrical signal in which action potentials to the brain are not blocked, and in which action potentials to a distal terminus of the nerve are partially or completely blocked or inhibited), followed by a plurality of microburst type signals during the normal off -time and delivered in the other direction (e.g., with the electrode polarities reversed such that action potentials to the brain are partially or completely blocked or inhibited, but action potentials to the distal terminus of the nerve are not blocked or inhibited).
- one electrode polarity configuration e.g., an electrical signal in which action potentials to the brain are not blocked, and in which action potentials to a distal terminus of the nerve are partially or completely blocked or inhibited
- a second exemplary stimulation regimen may call for a series of pulses in a first direction, followed by an off-time, and then followed by a series of pulses in the opposite direction.
- a third exemplary stimulation regimen may call for switching electrode polarity in a 2-electrode configuration after each pulse, such that propagation of action potentials in each direction are sequentially permitted and then at least partially blocked, then permitted again in alternating sequence.
- multiple pulses may be generated in a first electrode configuration, followed by switching electrode polarity to a second electrode configuration for one or a few pulses, followed by switching polarity back to the first electrode configuration.
- Information relating to the stimulation regimens may be used by the electrode polarity reversal unit 280 to control the operations of the first through nth switches 330(l-n).
- each of a plurality of stimulation regimens may respectively relate to a particular disorder.
- different regimens relating to the same disorder may be implemented to accommodate improvements or regressions in the patient's present condition relative to his or her condition at previous times.
- the switching controller 345 may be a processor that is capable of receiving data relating to the stimulation regimens. In an alternative embodiment, the switching controller may be a software or a firmware module. Based upon the particulars of the stimulation regimens, the switching timing unit 333 may provide timing data to the switching controller 345.
- the first through nth switches 330(l-n) may be electrical devices, electro-mechanical devices, and/or solid state devices (e.g., transistors).
- Figure 4 shows one embodiment of a method of performing changeable electrode polarity stimulation according to the present invention.
- the IMD 200 has a first normal stimulation mode in which it performs single polarity stimulation 410, i.e., stimulation in which only one electrode 125 of the IMD 200 is the cathode for delivery of electrical signals to the cranial nerve, such as vagus nerve 127, and in which the electrode polarities are only changed by manual programming.
- the IMD 200 checks 420 whether a signal to enter a changeable electrode polarity stimulation mode has been received.
- the signal to enter a changeable electrode polarity stimulation mode can be received, by way of nonlimiting examples, from the controller 210 ( Figure 2), from a sensor or sensors implanted in or on the patient's body which detect(s) one or more bodily parameters (e.g., heart rate, respiration rate, blood pressure, blood glucose, etc.), from a medical practitioner communicating with the device via wand 155 ( Figure 1), or a medical practitioner or patient using a magnet to provide a signal via the magnetic field detection unit 290. Regardless of the nature of the signal, if the IMD 200 does not detect it when checking 420, the IMD reverts to single polarity stimulation 410.
- bodily parameters e.g., heart rate, respiration rate, blood pressure, blood glucose, etc.
- the IMD 200 then implements a changeable electrode polarity stimulation mode shown in steps 430-460. Specifically, the IMD 200 delivers 430 a first predetermined number of pulses in a first polarity configuration of the electrodes.
- a first electrode 125(1) may be the cathode and a second electrode 125(2) may be the anode in step 430.
- the IMD 200 reverses 440 the polarity of the electrodes to a second polarity configuration.
- the first electrode 125(1) may be switched to be the anode and the second electrode 125(2) may be switched to be the cathode.
- Step 450 resembles step 430, though it will be noted the second polarity configuration differs from the first polarity configuration and the second predetermined number of pulses may differ in number of pulses or other stimulation parameters (pulse frequency, pulse width, On Time, Off Time, interpulse interval, number of pulses per burst, or interburst interval, among others) from the first predetermined number of pulses.
- Step 460 resembles step 440, though it will be noted it reverts the configuration of the electrodes to the first electrode polarity configuration as of step 430.
- the IMD 200 checks 470 whether a signal to discontinue the changeable electrode polarity stimulation mode has been received.
- the signal to discontinue the changeable electrode polarity stimulation mode can be received from the same sources described above in the context of checking step 420. Regardless of the nature of the signal, if the IMD 200 does not detect the signal when performing checking step 470, the IMD 200 continues changeable electrode polarity stimulation by returning to step 430. If the signal is detected when performing checking step 470, the IMD 200 reverts to single polarity stimulation 410.
- Figure 5 shows another embodiment of a method according to the present invention.
- the method comprises steps 530-560, which resemble steps 430-460 shown in Figure 4.
- the method shown in Figure 5 does not include single polarity stimulation; after the second reversal step 560 is performed, the IMD 200 continues changeable electrode polarity stimulation by returning to step 530.
- one or more of the properties of the first predetermined number of pulses can be changed upon each performance of step 430 or 530.
- the properties can be varied in a preprogrammed fashion, following programming executed by the controller 210, or can be varied according to data retrieved from a sensor of a bodily parameter of the patient or in response to instructions received from a medical practitioner or the patient.
- one or more of the properties of the second predetermined number of pulses can be changed upon each performance of step 450 or 550.
- the IMD 200 provides therapeutic stimulation signals via the stimulation unit 220.
- the stimulation unit 220 provides signals via leads that are coupled to a first electrode 610 and a second electrode 620.
- the first and second electrodes 610, 620 may be coupled to a portion of a tissue in a patient.
- the diagram in Figure 6 depicts a tissue impedance experienced at the nodes of the first and second electrodes 610, 620.
- the tissue impedance 630 may generally be constant with slight variations based on bodily changes.
- the tissue impedance may vary based upon hydration, pH changes, tissue fibrosis around the electrodes, electrode polarization, electrode metal oxidation, scar tissue formation, injury, infection, inflammation, and other factors related to electrolyte balance, or two or more thereof.
- the tissue impedance may vary based upon the acute-to- chronic transition from lead implant wherein the lead impedance may be 1800 Ohms soon after implant and 2800 Ohms a month after implant.
- the IMD 200 may also comprise a 1 st capacitor (Cl) in series with the first electrode 610, as well as a 2 nd capacitor (C2) in series with the second electrode 620.
- the 1 st and 2 nd capacitors Cl, C2 are provided for dissipating electrical charges built-up on the 1 st and 2 nd electrodes 610, 620 as a result of delivering therapeutic stimulation signals to the tissue impedance 630.
- the diagram of Figure 6 also illustrates a first node (i.e., first anode) at the distal end of the electrode 610 and a second node (i.e., first cathode) at the distal end of the second electrode 620.
- the electrode polarity reversal unit 280 is capable of switching or reversing the polarity of the first and second electrodes to provide the changeable electrode polarity stimulation provided herein.
- the anode and cathode functions performed by the first and second nodes, respectively may be reversed, wherein the first node transforms from being the anode to the cathode and the second node transforms from being the cathode to the anode.
- the 1 st and 2 nd capacitors Cl, C2 are capable of dissipating the charge build-up that results from the delivery of therapeutic electrical signal pulses to the tissue region represented by the tissue impedance 630.
- the stimulation unit 220 is capable of providing a controlled current signal that is exemplified in Figure 7A, which illustrates a current pulse signal.
- the delivery of the current illustrated in Figure 7A may result in a voltage, V, as illustrated in Figure 7B.
- the development of the voltage V as the current passes through the tissue impedance 630 is due to the flow of the current (I).
- V f i na i Vi n i t i a , * e ' ⁇ ; Equation 1
- V fmal is the steady state voltage across each capacitor Cl and C2 after the current pulse (I) is terminated.
- the voltage, Vi n j,j a i is the value of the voltage across Cl and C2 induced by the current pulse (I).
- the time-constant ⁇ defines the rate of decay (or rise) of the voltage across the capacitors Cl, C2.
- the time-constant ⁇ is defined by the capacitance value of C and the resistance experienced by the each capacitor Cl, C2.
- the charges built up in the capacitors Cl, C2, dissipate over time, resulting in a voltage rise from a negative level to zero in an asymptotic fashion as illustrated in Figure 7B.
- Figure 7C illustrates the signal response relating to the capacitor Cl upon the delivery of the current I. Since instantaneous change in voltage is not possible across the capacitor Cl, upon delivery of the current I, an asymptotic negative rise of voltage across Cl is realized. This voltage change is defined by the equation provided above. The voltage across the capacitor Cl is built up in the opposite polarity with reference to voltage V. Upon the termination of the pulse, the voltage stops increasing (in the negative direction) and asymptotically rises up to zero.
- Figure 7D illustrates that the capacitor C2 provides a rise in positive voltage in a similar manner. Upon termination of the current pulse I, the voltage across C2 decreases asymptotically to zero.
- Embodiments of the present invention provide for use of the remaining charges that may exist in the capacitors Cl and C2 and/or nodes of the electrodes, after the termination of an electrical signal pulse. These remaining charges may be used in the delivery of a subsequent electrical signal pulse. This may be achieved by reversing the polarities of the respective nodes of the first and second electrodes 610-620.
- Figure 8 illustrates a second configuration of an exemplary implementation of the IMD 200, in which the polarity of the first and second electrodes have been reversed from those shown in Figure 6.
- the first anode and the first cathode nodes have been reversed wherein the first anode of Figure 6 is now the second cathode of Figure 8, and the first cathode of Figure 6 is now the second anode of Figure 8.
- This reversal may be performed by the electrode polarity reversal unit 220 described above.
- the current I flows in the opposite direction upon application of a stimulation signal provided by the stimulation unit 220.
- the voltage V across the tissue impedance 630 is also reversed.
- Reversal of the polarities may provide for various therapeutic benefits described above.
- This type of reversal may be provided during changeable electrode polarity stimulation, wherein the first and the second electrode 610, are configured in a bilateral fashion (i.e., wherein first electrode may be coupled to the right vagus nerve and the second electrode 620 may be coupled to the left vagus nerve, or vice versa).
- the changeable electrode polarity system provided herein may be implemented in a unilateral configuration, such as both the first and second electrodes 610 and 620 being coupled to a single vagus nerve, such as the left vagus nerve.
- the distance between the first and second electrodes 610, 620 may vary from 1 mm to 50 mm.
- the electrodes may be spaced 1 cm apart for closely-spaced stimulation or 40 cm apart for distant stimulation.
- the pulse generator case 121 is an electrode
- the distance between an electrode 125 coupled to a cranial nerve and the pulse generator case 121 may vary from 1 mm to 300 mm.
- the distance between the electrodes 610, 620 may play a substantial part in targeting particular regions of a patient's body, in multiple directions.
- the cathode may be placed strategically such that signals in both directions may propagate to a certain limit, such as to a particular plexus, and then would be blocked in one direction by the anode.
- a proximal cranium signal may be delivered to the brain.
- the stimulation unit 220 may provide a therapeutic electrical signal pulse having a programmed current. Due to the reversal of the cathode and the anode (in relation to the configuration of Figure 6), the stimulation current I is represented as going from zero to a negative value and back, in a pulse form, as illustrated in Figure 9A. During the duration of the current pulse ( Figure 9A), the voltage V ( Figure 9B) develops across the tissue impedance 630 (i.e., between the second cathode and the second anode) in the same polarity as the current I. Upon termination of the current pulse I, the voltage is reversed due to the charges accumulated in the 1 st and 2 nd capacitors Cl, C2.
- Figure 8 causes the accumulation of voltage shown in Figure 9B to be in a negative direction compared to the configuration depicted and described in Figures 6 and 7.
- the discharge of the energy from the capacitors Cl and C2 provides for an asymptotic function of the voltage V as illustrated in Figure 9B.
- Figure 9C illustrates the signal-response in capacitor Cl to the electrical pulse shown in Figure 9 A.
- an asymptotical rise of voltage across the capacitor Cl in the opposite direction of the polarity of the current pulse I is produced.
- an asymptotic rise in voltage in the negative direction i.e., the same polarity of the current is generated
- the signal responses indicated by the dotted lines represent signals resulting from the delivery of an electrical signal pulse performed after reversal of the first and second electrodes' polarities (as illustrated in Figure 8).
- Figures 10A- 1OD also define shaded regions that represents the charge/energy accumulated by a preceding therapeutic stimulation signal.
- Figure 1OA illustrates a first cathode signal response based upon the configuration of Figure 6 (i.e., with the first electrode as a first anode and the second electrode as a first cathode).
- the first cathode is coupled to the distal portion of the second electrode 620.
- the stimulation unit 220 in Figure 6 applies an electrical signal current pulse
- the resultant signal at the first cathode provides a signal that is opposite in polarity to the current I ( Figure 10A).
- the capacitor C2 which in Figure 6 is a "cathode capacitor," provides an asymptotic rise in voltage until the termination of the current pulse, which then prompts an asymptotic decay (shaded region of Figure 10B) of the voltage.
- the first anode which is the output of the first electrode 610 in Figure 6, provides a signal with the same polarity as the current.
- An "anode capacitor” (Cl in the case of Figure 6) provides for an asymptotic negative rise in voltage, as illustrated in Figure 10D.
- an asymptotic positive rise to zero voltage across the anode capacitor occurs (shaded region of Figure 10D). Therefore, upon termination of the current pulse there remains a charge on the cathode capacitor (i.e., C2 in the configuration of Figure 6) and the anode capacitor (i.e., Cl in Figure 6). Both capacitors contain accumulated charge that may be discharged.
- the shaded regions in Figures 1OB and 1OD represent some lingering, accumulated charge/energy for a period of time, until they asymptotically decay.
- the accumulated charges in the capacitors Cl and C2 may be utilized in delivery of a subsequent electrical signal current pulse. If within the period of time in which there remains some charge/energy in the capacitors, as depicted by the shaded regions in Figures 1OB and 10D, an electrical signal current pulse delivered in those same directions (as the available charges/energy in Figure 1OB and 10D) would result in a boost in the signals delivered by the electrodes in the second configuration of Figure 8. This is illustrated by the dotted lines in Figure 1OA and 1OC.
- an electrode polarity reversal may be performed by the electrode polarity reversal unit 280. After reversing the polarity of the electrodes, the first cathode will become the second anode and the first anode will become the second cathode. In this manner, a pulse current signal in the opposite polarity is delivered, which would coincide with the polarity of the stored charges by the cathode capacitor and the anode capacitor.
- the second anode signal receives a charge boost for the portion of the pulse that overlaps the time period where there still remains stored charges/energy in the cathode capacitor. This is indicated by the shaded region ("second anode charge boost") of Figure 1OA. Therefore, the stimulation unit 220 may generate and provide a smaller amount of energy to achieve a sufficient rise in the pulse current to obtain a desired amplitude because of the charge boost provided by the capacitor, as illustrated in Figure 1OA. Due to the feedback control current nature of the operation of the HMD 200, less charge proportionally is used than in cases where the charge on the capacitor completely decays, such that the second anode charge boost provides for a percentage of the total charge needed to provide the pulse illustrated in dotted lines in Figure 1OA.
- the second cathode also experiences a second cathode charge boost, as illustrated in Figure 1OC, due to the accumulated charge/energy remaining in the anode capacitor of Figure 10D. While an accumulated charge is present on the anode capacitor, a portion of the negative-polarity pulse is boosted by the existing charge on the anode capacitor. In this manner, leftover charges are utilized to provide energy for subsequent pulses. This may provide considerable savings in charge usage from the battery of the IMD 200.
- the anode and cathode nodes may be reversed continuously (i.e., repeating the reversals several times) to take advantage of the existing charge from the previous delivery of a pulse, while delivering changeable electrode polarity stimulation, hi alternative embodiments, the polarity reversals of the cathode and the anode may only be performed periodically, hi such alternative embodiments, therefore, some resident charges may be dissipated by the capacitor Cl and C2 while some charges may be utilized during those times when the anode and the cathode nodes are reversed, hi this manner, substantial savings in charge-usage may be realized utilizing the changeable electrode polarity stimulation provided herein.
- 80% or more of the electrical charge necessary for an electrical signal pulse may be provided by the energy stored in the capacitors.
- embodiments of the present invention were described as in a two-electrode configuration. However, those skilled in the art having benefit of the present disclosure, would readily appreciate that a variety of configurations, with any number of electrodes, may be implemented and remain within the spirit and scope of the present invention.
- the above-described implementations may be provided in a bilateral configuration, as well as in a unilateral configuration. Therefore, utilizing the embodiments of the present invention, substantial appreciation in efficacy and power savings may be realized.
- a first electrode and a second electrode are directly coupled to a first ventricle of the heart and a second ventricle of the heart. This embodiment may realize substantial appreciation in efficacy, power savings, or both in a pacemaker device.
Abstract
We disclose a method, apparatus, and system of treating a medical condition in a patient using an implantable medical device. A first electrode is coupled to a first portion of a cranial nerve of the patient. A second electrode is coupled to a second portion of the cranial nerve of the patient. A first electrical signal is provided to the first and second electrodes. The first electrical signal is provided in a first polarity configuration in which the first electrode functions as an anode and the second electrode functions as a cathode. Upon termination of the first electrical signal, the anode and cathode each comprise a first accumulated energy. A second electrical signal is provided to the first and second electrodes, in which the second electrical signal includes at least a portion of the first accumulated energy.
Description
METHOD, APPARATUS AND SYSTEM FOR BIPOLAR CHARGE UTILIZATION DURING STIMULATION BY AN IMPLANTABLE
MEDICAL DEVICE
BACKGROUND OF THE INVENTION
1. FIELD OF THE INVENTION
This invention relates generally to medical devices, and, more particularly, to methods, apparatus, and systems for providing improved charge utilization when providing an electrical signal therapy by a medical device.
2. DESCRIPTION OF THE RELATED ART
There have been many improvements over the last several decades in medical treatments for disorders of the nervous system, such as epilepsy and other motor disorders, and abnormal neural discharge disorders. One of the more recently available treatments involves the application of an electrical signal to reduce various symptoms or effects caused by such neural disorders. For example, electrical signals have been successfully applied at strategic locations in the human body to provide various benefits, including reducing occurrences of seizures and/or improving or ameliorating other conditions. A particular example of such a treatment regimen involves applying an electrical signal to the vagus nerve of the human body to reduce or eliminate epileptic seizures, as described in U.S. Patent Nos. 4,702,254, 4,867,164, and 5,025,807 to Dr. Jacob Zabara, which are hereby incorporated in this specification in their entirety by reference.
More generally, the endogenous electrical activity (Le., activity attributable to the natural functioning of the patient's own body) of a neural structure of a patient may be modulated in a variety of ways. In particular, the electrical activity may be modulated by exogenously applied (i.e., from a source other than the patient's own body) electrical, chemical, or mechanical signals applied to the neural structure. The modulation (hereinafter referred to generally as "neurostimulation" or "neuromodulation") may involve the induction of afferent action potentials, efferent action potentials, or both, in the neural structure, and may also involve blocking or interrupting the transmission of endogenous electrical activity traveling along the nerve. Electrical signal therapy or electrical modulation of a neural structure (also known as "electrical signal therapy") refers to the application of an exogenous therapeutic electrical signal (as opposed to a chemical or mechanical signal), to the neural structure. Electrical signal therapy may be provided by implanting an electrical device underneath the skin of a patient and delivering an electrical signal to a nerve such as a cranial nerve. The electrical signal therapy may involve performing a detection step, with the electrical signal being delivered in response to a detected body parameter. This type of stimulation is generally referred to as "active," "feedback," or "triggered" stimulation. Alternatively, the system may operate without a detection system once the patient has been diagnosed with epilepsy (or another medical condition), and may periodically apply a series of electrical pulses to the nerve (e.g., a cranial nerve such as a vagus nerve) intermittently throughout the day, or over another predetermined time interval. This type of stimulation is generally referred to as "passive," "non-feedback," or "prophylactic," stimulation. The stimulation may be applied by an implantable medical device that is implanted within the patient's body.
A number of medical conditions that are amenable to electrical signal therapy via cranial nerve stimulation present symptoms in regions outside the brain. For example, disorders of the neurological system, the gastrointestinal system, the pancreas, or the kidneys, feature impaired or improper function of those organs. Diabetes, particularly type I diabetes, often features impaired production of insulin by the islets of Langerhans in the pancreas. Electrical signal stimulation of either the brain alone or the organ alone may have some efficacy in treating such medical conditions, but may not have maximal efficacy.
Therefore, a need exists for apparatus and methods for performing electrical signal stimulation of both the brain and an organ outside the brain. A need also exists for apparatus and methods for performing electrical signal stimulation with increased efficacy.
SUMMARY OF THE INVENTION
In one aspect, the present invention relates to a method of treating a medical condition in a patient using an implantable medical device. A first electrode is coupled to a first portion of a cranial nerve of the patient. A second electrode is coupled to a second portion of the cranial nerve of the patient. A first electrical pulse is provided to the first and second electrodes. The first electrical pulse is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode. Upon termination of the first signal pulse, the anode and cathode each comprises an accumulated energy. A second electrical pulse is provided to the first and second electrodes. The second electrical pulse comprises at least a portion of the accumulated energy.
In another aspect, the present invention relates to another method for treating a medical condition in a patient using an implantable medical device. A first electrical signal is
provided to a first electrode coupled to a first portion of a cranial nerve of the patient, as well as to a second electrode coupled to a second portion of a cranial nerve of the patient. The first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode. The anode and cathode each comprises an accumulated energy based upon the first signal pulse. A second configuration of the electrodes is provided upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode function as the anode. A second electrical signal is provided to the first and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy.
In yet another aspect, the present invention relates to another method for treating a medical condition in a patient using an implantable medical device. A first electrode is coupled to a portion of a right cranial nerve of the patient. A second electrode is coupled to a portion of a left cranial nerve of the patient. A first electrical signal is provided to the first and second electrodes. The first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode. Upon termination of the first electrical signal, the anode and cathode each comprise an accumulated energy. A second configuration of the electrodes is provided upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode function as the anode. A second electrical signal is provided to the first and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy.
In another aspect, the present invention relates to an implantable medical device for treating a medical condition in a patient. The device includes a controller capable of
receiving data and controlling the operation of the implantable medical device by providing at least one control parameter. The device also includes a stimulation unit for generating and delivering, based upon the at least one control parameter, a first electrical signal to a first electrode electrically coupled to a first portion of a cranial nerve and to a second electrode electrically coupled to a second cranial nerve. The first electrical signal is provided in a first configuration, in which the first electrode functions as an anode and the second electrode functions as a cathode. Upon termination of the first electrical signal, the anode and cathode each includes an accumulated energy resulting from the first electrical signal. The device also comprises an electrode polarity reversal unit that is capable of changing the configuration of the first and second electrodes from the first configuration to the second configuration. The stimulation unit also generates and delivers a second electrical signal to the first and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy. hi yet another aspect, the present invention relates to a computer readable program storage device encoded with instructions that, when executed by a computer, performs a method for treating a medical condition in a patient. The method includes providing a first electrical signal to a first electrode coupled to a first portion of a cranial nerve of the patient, and to a second electrode coupled to a second portion of a cranial nerve of the patient. The first electrical signal is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode. Upon termination of the first electrical signal, the anode and cathode each includes an accumulated energy. The method also includes providing a second configuration of the electrodes upon termination of the first electrical signal. In the second configuration, the first electrode functions as the cathode and the second electrode functions as the anode. A second electrical signal is provided to the first
and second electrodes in the second configuration. The second electrical signal comprises at least a portion of the accumulated energy.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention may be understood by reference to the following description taken in conjunction with the accompanying drawings, in which like reference numerals identify like elements, and in which:
Figures 1A-1C provide stylized diagrams of an implantable medical device implanted into a patient's body for providing electrical signals to a portion of the patient's body, in accordance with one illustrative embodiment of the present invention;
Figure 2 illustrates a block diagram depiction of the implantable medical device of
Figure 1, in accordance with one illustrative embodiment of the present invention;
Figure 3 illustrates a block diagram depiction of an electrode polarity reversal unit shown in Figure 2, in accordance with one illustrative embodiment of the present invention;
Figure 4 illustrates a flowchart depiction of a method for performing limited patient- initiated electrical signal therapy, in accordance with an illustrative embodiment of the present invention;
Figure 5 illustrates a flowchart depiction of a method for performing limited patient- initiated electrical signal therapy, in accordance with another illustrative embodiment of the present invention;
Figure 6 illustrates an implementation of the IMD of Figure 2 and related electrodes in an illustrative configuration, in accordance with one illustrative embodiment of the present invention;
Figures 7A-7D provide various diagrams illustrating electrical characteristics of signals generated by the IMD 200 in the configuration provided in Figure 6;
Figure 8 illustrates a reversed configuration of the IMD relative to the configuration illustrated in Figure 6, in accordance with one illustrative embodiment of the present invention;
Figures 9A-9D provide various diagrams illustrating electrical characteristics of signals generated by the IMD 200 in the configuration provided in Figure 8; and
Figures 10A- 1OD provide various electrical diagrams of signals at various nodes of the configuration illustrated in Figures 6 and 8, in accordance with one illustrative embodiment of the present invention.
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS
Illustrative embodiments of the invention are described herein. In the interest of clarity, not all features of an actual implementation are described in this specification. In the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the design- specific goals, which will vary from one implementation to another. It will be appreciated that such a development effort, while possibly complex and time-consuming, would nevertheless be a routine undertaking for persons of ordinary skill in the art having the benefit of this disclosure.
This document does not intend to distinguish between components that differ in name but not function. In the following discussion and in the claims, the terms "including" and
"includes" are used in an open-ended fashion, and thus should be interpreted to mean
"including, but not limited to." Also, the term "couple" or "couples" is intended to mean either a direct or an indirect electrical .connection. "Direct contact," "direct attachment," or providing a "direct coupling" indicates that a surface of a first element contacts the surface of a second element with no substantial attenuating medium there between. The presence of small quantities of substances, such as bodily fluids, that do not substantially attenuate electrical connections does not vitiate direct contact. The word "or" is used in the inclusive sense (i.e., "and/or") unless a specific use to the contrary is explicitly stated.
The term "electrode" or "electrodes" described herein may refer to one or more stimulation electrodes (i.e., electrodes for delivering an electrical signal generated by an IMD to a tissue), sensing electrodes (i.e., electrodes for sensing a physiological indication of a patient's body), and/or electrodes that are capable of delivering a stimulation signal, as well as performing a sensing function.
Cranial nerve stimulation, such as vagus nerve stimulation (VNS), has been proposed to treat a number of medical conditions pertaining to or mediated by one or more structures of the nervous system of the body, including epilepsy and other movement disorders, depression, anxiety disorders and other neuropsychiatric disorders, dementia, head trauma, coma, migraine headache, obesity, eating disorders, sleep disorders, cardiac disorders (such as congestive heart failure and atrial fibrillation), hypertension, endocrine disorders (such as diabetes and hypoglycemia), and pain, among others. See, e.g., U.S. Pats. Nos. 4,867,164; 5,299,569; 5,269,303; 5,571,150; 5,215,086; 5,188,104; 5,263,480; 6,587,719; 6,609,025; 5,335,657; 6,622,041; 5,916,239; 5,707,400; 5,231,988; and 5,330,515. Despite the numerous disorders for which cranial nerve stimulation has been proposed or suggested as a treatment option, the fact that detailed neural pathways for many (if not all) cranial nerves remain relatively unknown, makes predictions of efficacy for any given disorder difficult or impossible. Moreover, even if such pathways were known, the precise stimulation parameters that would modulate particular pathways relevant to a particular disorder generally cannot be predicted.
In one embodiment, the present invention provides a method of treating a medical condition. The medical condition can be selected from the group consisting of epilepsy, neuropsychiatric disorders (including but not limited to depression), eating disorders/obesity, traumatic brain injury/coma, addiction disorders, dementia, sleep disorders, pain, migraine, endocrine/pancreatic disorders (including but not limited to diabetes), motility disorders, hypertension, congestive heart failure/cardiac capillary growth, hearing disorders, angina, syncope, vocal cord disorders, thyroid disorders, pulmonary disorders, gastrointestinal disorders, kidney disorders, and reproductive endocrine disorders (including infertility).
In a further embodiment, the medical condition is selected from the group consisting of depression, epilepsy, obesity, bulimia, traumatic brain injury, congestive heart failure, stroke, coma, fibromyalgia, addiction disorders, multiple sclerosis, haring disorder,
Alzheimer's disease, Parkinson's disease, gastrointestinal disorders, pancreatic disorders, kidney disorders, and diabetes.
Still further, embodiments of the present invention provide for performing a bipolar stimulation utilizing a node reversal technique. The bipolar stimulation may be implemented in a bilateral and/or a unilateral fashion, e.g., in vagus nerve stimuation, to both the left and right branches of the vagus nerve (bilateral stimulation), or to the left vagus nerve alone or the right vagus nerve alone (unilateral stimulation). Utilizing the node reversal technique of reversing the cathode and the anode of a signal delivery location, efficiency in charge usage may be realized. Embodiments of the present invention provide for utilizing the excess charges resulting from delivery of a previously applied therapeutic electrical signal. The excess charges may be used in a manner whereupon reversal of electrical nodes of electrodes associated with an IMD may be used to boost a subsequently generated and applied electrical signal, thereby realizing improved efficiencies and charge usage. Utilizing techniques provided by the present invention, increase of charge efficiency resulting in decrease of charge usage in the order of 80% or above may be realized.
Although not so limited, a system capable of implementing embodiments of the present invention is described below. Figures IA- 1C depict a stylized implantable medical system 100 for implementing one or more embodiments of the present invention. Figures
IA- 1C illustrate an electrical signal generator 110 having main body 112 comprising a case or shell 121 (Figure IB) with a header 116 (Figure IA, IB) for connecting to leads 122. The
generator 110 is implanted in the patient's chest in a pocket or cavity formed by the implanting surgeon just below the skin (indicated by a line 145, Figure IA), similar to the implantation procedure for a pacemaker pulse generator.
A stimulating nerve electrode assembly 125, preferably comprising at least an electrode pair, is conductively connected to the distal end of an insulated, electrically conductive lead assembly 122, which preferably comprises a pair of lead wires (one wire for each electrode of an electrode pair). Lead assembly 122 is attached at its proximal end to connectors on the header 116 (Figure IB) on case 121. The electrode assembly 125 may be surgically coupled to a cranial nerve, such as vagus nerve 127, in the patient's neck or head, or at another location, e.g., near the patient's diaphragm. Other cranial nerves, such as the trigeminal and/or glossopharyngeal nerves, may also be used to deliver the therapeutic electrical signal. The electrode assembly 125 preferably comprises a bipolar stimulating electrode pair 125-1, 125-2 (Figure 1C), such as the electrode pair described in U.S. Pat. No. 4,573,481 issued March 4, 1986 to Bullara. Suitable electrode assemblies are available from Cyberonics, Inc., Houston, Texas, USA as the Model 302 electrode assembly. However, persons of skill in the art will appreciate that many electrode designs could be used in the present invention, including unipolar electrodes. Returning to Figures IA and 1C, the two electrodes are preferably wrapped about the cranial nerve, such as vagus nerve 127, and the electrode assembly 125 may be secured to the nerve by a spiral anchoring tether 128 (Figure 1C) such as that disclosed in U.S. Pat. No. 4,979,511 issued Dec. 25, 1990 to Reese S. Terry, Jr. and assigned to the same assignee as the instant application. Lead assembly 122 is secured, while retaining the ability to flex with movement of the chest and neck, by a suture connection 130 to nearby tissue (Figure 1C).
In one embodiment, the open helical design of the electrode assembly 125 (described in detail in the above-cited Bullara patent), which is self-sizing and flexible, minimizes mechanical trauma to the nerve and allows body fluid interchange with the nerve. The electrode assembly 125 preferably conforms to the shape of the nerve, providing a low stimulation threshold by allowing a large stimulation contact area with the nerve. Structurally, the electrode assembly 125 comprises two electrode ribbons (not shown), of a conductive material such as platinum, iridium, platinum-iridium alloys, and/or oxides of the foregoing. The electrode ribbons are individually bonded to an inside surface of an elastomeric body portion of the two spiral electrodes 125-1 and 125-2 (Figure 1C), which may comprise two spiral loops of a three-loop helical assembly. The lead assembly 122 may comprise two distinct lead wires or a coaxial cable whose two conductive elements are respectively coupled to one of the conductive electrode ribbons. One suitable method of coupling the lead wires or cable to the electrodes 125-1, 125-2 comprises a spacer assembly such as that disclosed in US 5,531,778, although other known coupling techniques may be used.
The elastomeric body portion of each loop is preferably composed of silicone rubber, and the third loop 128 (which typically has no electrode) acts as the anchoring tether for the electrode assembly 125.
In one embodiment, a first electrode is coupled to a first portion of a first electrically- stimulatable structure of the patient, and a second electrode is coupled to a second portion of a second electrically-stimulatable structure of the patient. The person of ordinary skill in the art can, in light of the present disclosure, identify electrically-stimulatable structures of the patient as a matter of routine experimentation. By coupling the electrodes as described in this
paragraph, electrical signal stimulation can be effected on any electrically-stimulatable structure of the patient. In one embodiment, the first electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart, and the second electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart.
In one embodiment, the pulse generator case 121 can function as an electrode. In this embodiment, one or more electrodes 125 can be coupled to a cranial nerve, such as the vagus nerve 127, for delivery of electrical signals to the cranial nerve, and the pulse generator case 121 can be located in proximity to a tissue for delivery of electrical signals to the tissue.
The electrical pulse generator 110 may be programmed with an external computer 150 using programming software of a type known in the art for stimulating neural structures, or other suitable software based on the description herein, and a programming wand 155 to facilitate radio frequency (RF) communication between the computer 150 (Figure IA) and the pulse generator 110. The wand 155 and software permit wireless, non-invasive communication with the generator 110 after the latter is implanted. The wand 155 is preferably powered by internal batteries, and provided with a "power on" light to indicate sufficient power for communication. Another indicator light may be provided to show that data transmission is occurring between the wand and the generator.
A variety of stimulation therapies may be provided in implantable medical systems 100 of the present invention. Different types of nerve fibers (e.g., A, B, and C-fibers being different fibers targeted for stimulation) respond differently to stimulation from electrical signals. More specifically, the different types of nerve fibers have different conduction velocities and stimulation thresholds and, therefore, differ in their responsiveness to
stimulation. Certain pulses of an electrical stimulation signal, for example, may be below the stimulation threshold for a particular fiber and, therefore, may generate no action potential in the fiber. Thus, smaller or narrower pulses may be used to avoid stimulation of certain nerve fibers (such as C-fibers) and target other nerve fibers (such as A and/or B fibers, which generally have lower stimulation thresholds and higher conduction velocities than C-fibers). Additionally, techniques such as pre-polarization may be employed wherein particular nerve regions may be polarized before a more robust stimulation is delivered, which may better accommodate particular electrode materials. Furthermore, opposing polarity phases separated by a zero current phase may be used to excite particular axons or postpone nerve fatigue during long term stimulation.
As used herein, the terms "stimulating" and "stimulator" may generally refer to delivery of a signal, stimulus, or impulse to neural tissue for affecting neuronal activity of a neural tissue (e.g., a volume of neural tissue in the brain or a nerve). The effect of such stimulation on neuronal activity is termed "modulation"; however, for simplicity, the terms "stimulating" and "modulating", and variants thereof, are sometimes used interchangeably herein. The effect of delivery of the stimulation signal to the neural tissue may be excitatory or inhibitory and may potentiate acute and/or long-term changes in neuronal activity. For example, the effect of "stimulating" or "modulating" a neural tissue may comprise one or more of the following effects: (a) changes in neural tissue to initiate an action potential (bi- directional or uni-directional); (b) inhibition of conduction of action potentials (endogenous or externally stimulated) or blocking the conduction of action potentials (hyperpolarizing or collision blocking), (c) affecting changes in neurotransmitter/neuromodulator release or uptake, and (d) changes in neuro-plasticity or neurogenesis of brain tissue. Applying an electrical signal to an autonomic nerve may comprise generating a response that includes an
afferent action potential, an efferent action potential, an afferent hyperpolarization, an efferent hyperpolarization, an afferent sub-threshold depolarization, and/or an efferent subthreshold depolarization.
In one embodiment, the stimulation method includes the steps of generating a first electrical signal with the electrical signal generator, applying the first electrical signal to the electrodes, wherein the first electrode is a cathode and the second electrode is an anode, reversing the polarity of the first electrode and the second electrode, yielding a configuration wherein the first electrode is an anode and the second electrode is a cathode, generating a second electrical signal with the electrical signal generator, applying the second electrical signal to the electrodes, reversing the polarity of the first electrode and the second electrode, yielding a configuration wherein the first electrode is a cathode and the second electrode is an anode, generating a third electrical signal with the electrical signal generator, and applying the third electrical signal to the electrodes.
In one embodiment, the first electrical signal, the second electrical signal, and the third electrical signal are substantially identical. In another embodiment, the first electrical signal may vary from the second electrical signal, the third electrical signal, or both in terms of one or more of pulse width, number of pulses, amplitude, frequency, stimulation on-time, and stimulation off- time, among other parameters.
The first electrical signal, the second electrical signal, and the third electrical signal are described herein in terms of exemplary illustrations. The person of ordinary skill in the art having benefit of the present disclosure would appreciate that more than three electrical signals, up to an nth electrical signal, can be used and are within the scope of the present invention.
"Cathode" and "anode" have their standard meanings, as the electrode at which current leaves the IMD system and the electrode at which current enters the IMD system, respectively. Reversing the polarity of the electrodes can be effected by any switching technique known in the art. A "pulse" is used herein to refer to a single application of electrical charge from the cathode to the cranial nerve. Individual pulses are separated by a time period in which no charge is delivered to the nerve, which can be called the "interpulse interval." A "burst" is used herein to refer to a plurality of pulses, wherein no charge is delivered to the nerve before the first pulse of the burst for a time period at least twice as long as the interpulse interval and no charge is delivered to the nerve after the last pulse of the burst for a time period at least twice as long as the interpulse interval. The time period between the end of the last pulse of a first burst and the initiation of the first pulse of the next subsequent burst can be called the "interburst interval." In one embodiment, the interburst interval is at least 100 msec.
A plurality of pulses can refer to any of (a) a number of consecutive pulses within a burst, (b) all the pulses of a burst, or (c) a number of consecutive pulses including the final pulse of a first burst and the first pulse of the next subsequent burst.
Each of the first, second, and third electrical signals can independently contain one or more pulses. In one embodiment, the first electrical signal contains one or more pulses, the second electrical signal contains one or more pulses, and the third electrical signal contains one or more pulses. In a further embodiment, the first electrical signal contains one pulse, the second electrical signal contains one pulse, and the third electrical signal contains one pulse.
The number of pulses contained within the first and second electrical signals or the second and third electrical signals need not be equal, and can be in any ratio. In one
embodiment, the ratio is from about 1:100 to about 100:1. In a further embodiment, the ratio is from about 1 : 10 to about 10:1.
In one embodiment, the first electrical signal contains a first number of pulses, the second electrical signal contains a second number of pulses, and the third electrical signal contains a third number of pulses, wherein the first number of pulses is not equal to the second number of pulses or the second number of pulses is not equal to the third number of pulses.
In another embodiment, the first electrical signal contains one or more bursts, the second electrical signal contains one or more bursts, and the third electrical signal contains one or more bursts. In a further embodiment, the first electrical signal contains one burst, the second electrical signal contains one burst, and the third electrical signal contains one burst.
The number of bursts contained within the first and second electrical signals or the second and third electrical signals need not be equal, and can be in any ratio. In one embodiment, the ratio is from about 1:100 to about 100:1. In a further embodiment, the ratio is from about 1:10 to about 10:1.
In one embodiment, the first electrical signal contains a first number of bursts, the second electrical signal contains a second number of bursts, and the third electrical signal contains a third number of bursts, wherein the first number of bursts is not equal to the second number of bursts or the second number of bursts is not equal to the third number of bursts.
Typical cranial nerve stimulation can be performed with an interpulse frequency of 20-30 Hz (resulting in a number of pulses per burst of 140-1800, at a burst duration from 7- 60 sec). In one embodiment, at least one of the first electrical signal, the second electrical signal, and the third electrical signal delivers microbursts. Microburst neurostimulation is
discussed by US 11/693,451, filed March 2, 2007 and published as United States patent Publication No. 20070233193, and incorporated herein by reference. In one embodiment, at least one of the first electrical signal, the second electrical signal, and the third electrical signal is characterized by having a number of pulses per microburst from 2 pulses to about 25 pulses, an interpulse interval of about 2 msec to about 50 msec, an interburst period of at least 100 msec, and a microburst duration of less than about 1 sec.
As stated above, different fiber types of cranial nerves propagate action potentials at different velocities. In one embodiment of the method, after performance of a prior applying step, the subsequent applying step is performed after an action potential induced by the prior applying step in A-fibers of the cranial nerve has passed the anode of the subsequent applying step and before an action potential induced by the prior applying step in C-fibers of the cranial nerve reaches the anode of the subsequent applying step. As a result, in this embodiment, an action potential induced in the A-fibers in the prior applying step can propagate along the nerve in the direction from the cathode of the prior applying step to the anode of the prior applying step and beyond to the brain or the distal terminus of the cranial nerve. Whereas, an action potential induced in the C-fibers in the prior applying step, though originally propagating along the nerve in the direction from the cathode of the prior applying step to the anode of the prior applying step, can be blocked by an electrical stimulation performed at the anode of the subsequent applying step, which was the cathode of the prior applying step. To generalize, by performing this method, particular fiber types in the cranial nerve can be selectively stimulated to propagate an action potential to either the proximal terminus (i.e., the brain) or distal terminus of the cranial nerve.
Turning now to Figure 2, a block diagram depiction of an implantable medical device, in accordance with one illustrative embodiment of the present invention is illustrated. The
IMD 200 may be coupled to various leads, e.g., 122 (Figures IA, 1C). Stimulation signals used for therapy may be transmitted from the IMD 200 to target areas of the patient's body, specifically to various electrodes associated with the leads 122. Stimulation signals from the IMD 200 may be transmitted via the leads 122 to stimulation electrodes (electrodes that apply the therapeutic electrical signal to the target tissue) associated with the electrode assembly 125, e.g., 125-1, 125-2 (Figure IA). Further, signals from sensor electrodes (electrodes that are used to sense one or more body parameters such as temperature, heart rate, brain activity, etc.) may also traverse the leads back to the IMD 200.
The IMD 200 may comprise a controller 210 capable of controlling various aspects of the operation of the IMD 200. The controller 210 is capable of receiving internal data and/or external data and controlling the generation and delivery of a stimulation signal to target tissues of the patient's body. For example, the controller 210 may receive manual instructions from an operator externally, or may perform stimulation based on internal calculations and programming. The controller 210 is capable of affecting substantially all functions of the IMD 200.
The controller 210 may comprise various components, such as a processor 215, a memory 217, etc. The processor 215 may comprise one or more micro controllers, micro processors, etc., that are capable of executing a variety of software components. The memory 217 may comprise various memory portions, where a number of types of data (e.g., internal data, external data instructions, software codes, status data, diagnostic data, etc.) may be stored. The memory 217 may store various tables or other database content that could be used by the IMD 200 to implement the override of normal operations. The memory 217 may comprise random access memory (RAM) dynamic random access memory (DRAM), electrically erasable programmable read-only memory (EEPROM), flash memory, etc.
The IMD 200 may also comprise a stimulation unit 220. The stimulation unit 220 is capable of generating and delivering a variety of electrical signal therapy signals to one or more electrodes via leads. The stimulation unit 220 is capable of delivering a programmed, primary mode electrical signal to the leads 122 coupled to the IMD 200. The electrical signal may be delivered to the leads 122 by the stimulation unit 220 based upon instructions from the controller 210. The stimulation unit 220 may comprise various types of circuitry, such as stimulation signal generators, impedance control circuitry to control the impedance "seen" by the leads, and other circuitry that receives instructions relating to the type of stimulation to be performed.
The IMD 200 may also comprise an electrode polarity reversal unit 280. The electrode polarity reversal unit 280 is capable of reversing the polarity of electrodes associated with the electrode assembly 125. The electrode polarity reversal unit 280 is shown in more detail in Figure 3. In preferred embodiments, the electrode polarity reversal unit is capable of reversing electrode polarity rapidly, i.e., in about 10 microseconds or less, and in any event at a sufficiently rapid rate to permit electrode polarities to be changed between adjacent pulses in a pulsed electrical signal.
The IMD 200 may also comprise a power supply 230. The power supply 230 may comprise a battery, voltage regulators, capacitors, etc., to provide power for the operation of the IMD 200, including delivering the stimulation signal. The power supply 230 comprises a power-source battery that in some embodiments may be rechargeable. In other embodiments, a non-rechargeable battery may be used. The power supply 230 provides power for the operation of the IMD 200, including electronic operations and the stimulation function. The power supply 230, may comprise a lithium/thionyl chloride cell or a lithium/carbon
monofluoride (LiCFx) cell. Other battery types known in the art of implantable medical devices may also be used.
The IMD 200 also comprises a communication unit 260 capable of facilitating communications between the IMD 200 and various devices. In particular, the communication unit 260 is capable of providing transmission and reception of electronic signals to and from an external unit 270. The external unit 270 may be a device that is capable of programming various modules and stimulation parameters of the IMD 200. In one embodiment, the external unit 270 comprises a computer system that is capable of executing a data- acquisition program. The external unit 270 may be controlled by a healthcare provider, such as a physician, at a base station in, for example, a doctor's office. The external unit 270 may be a computer, preferably a handheld computer or PDA, but may alternatively comprise any other device that is capable of electronic communications and programming. The external unit 270 may download various parameters and program software into the IMD 200 for programming the operation of the implantable device. The external unit 270 may also receive and upload various status conditions and other data from the IMD 200. The communication unit 260 may be hardware, software, firmware, and/or any combination thereof. Communications between the external unit 270 and the communication unit 260 may occur via a wireless or other type of communication, illustrated generally by line 275 in Figure 2.
In one embodiment, the communication unit 260 can transmit a log of stimulation data to the patient, a physician, or another party.
The LVID 200 is capable of delivering stimulation that can be intermittent, periodic, random, sequential, coded, and/or patterned. The stimulation signals may comprise an electrical stimulation frequency of approximately 0.1 to 2500 Hz. The stimulation signals
may comprise a pulse width in the range of approximately 1 - 2000 micro-seconds. The stimulation signals may comprise current amplitude in the range of approximately 0.1 mA to 10 mA. The stimulation delivered by the IMD 200 according to its programming may be referred to herein as "normal operations" or as a "normal operating mode."
The EMD 200 may also comprise a magnetic field detection unit 290. The magnetic field detection unit 290 is capable of detecting magnetic and/or electromagnetic fields of a predetermined magnitude. Whether the magnetic field results from a magnet placed proximate to the IMD 200, or whether it results from a substantial magnetic field encompassing an area, the magnetic field detection unit 290 is capable of informing the IMD of the existence of a magnetic field. The changeable electrode polarity stimulation described herein may be activated, deactivated, or alternatively activated or deactivated using a magnetic input.
The magnetic field detection unit 290 may comprise various sensors, such as a Reed Switch circuitry, a Hall Effect sensor circuitry, and/or the like. The magnetic field detection unit 290 may also comprise various registers and/or data transceiver circuits that are capable of sending signals that are indicative of various magnetic fields, the time period of such fields, etc. In this manner, the magnetic field detection unit 290 is capable of detecting whether the detected magnetic field relates to an inhibitory input or an excitory input from an external source. The inhibitory input may refer to an inhibition of, or a deviation from, normal stimulation operation. The excitory input may refer to additional stimulation or deviation from normal stimulation.
One or more of the blocks illustrated in the block diagram of the IMD 200 in Figure 2, may comprise hardware units, software units, firmware units, or any combination thereof.
Additionally, one or more blocks illustrated in Figure 2 may be combined with other blocks, which may represent circuit hardware units, software algorithms, etc. Additionally, one or more of the circuitry and/or software units associated with the various blocks illustrated in Figure 2 may be combined into a programmable device, such as a field programmable gate array, an ASIC device, etc.
Figure 3 shows in greater detail the electrode polarity reversal unit 280 (Figure 2). The electrode polarity reversal unit 280 comprises an electrode configuration switching unit 340, which includes a switching controller 345. The switching controller 345 transmits signals to one or more switches, generically, n switches 330(1), 330(2), ... 330(n) which effect the switching of the configuration of two or more electrodes, generically, n electrodes 125(1), 125(2), ... \25(n). Although Figure 3 shows equal numbers of switches 330 and electrodes 125, the person of ordinary skill in the art having the benefit of the present disclosure will understand that the number of switches 330 and their connections with the various electrodes 125 can be varied as a matter of routine optimization. A switching timing unit 333 can signal to the electrode configuration switching unit 340 that a desired time for switching the electrode configuration has been reached.
Instructions for implementing a series of predetermined and/or programmable stimulation regimens may be stored in the IMD 200. These stimulation regimens may include data relating to the type of changeable electrode polarity stimulation to be implemented. For example, a first stimulation regimen may call for a particular type of pulse signal in one direction and having one electrode polarity configuration {e.g., an electrical signal in which action potentials to the brain are not blocked, and in which action potentials to a distal terminus of the nerve are partially or completely blocked or inhibited), followed by
a plurality of microburst type signals during the normal off -time and delivered in the other direction (e.g., with the electrode polarities reversed such that action potentials to the brain are partially or completely blocked or inhibited, but action potentials to the distal terminus of the nerve are not blocked or inhibited). A second exemplary stimulation regimen may call for a series of pulses in a first direction, followed by an off-time, and then followed by a series of pulses in the opposite direction. A third exemplary stimulation regimen may call for switching electrode polarity in a 2-electrode configuration after each pulse, such that propagation of action potentials in each direction are sequentially permitted and then at least partially blocked, then permitted again in alternating sequence. In other embodiments, multiple pulses may be generated in a first electrode configuration, followed by switching electrode polarity to a second electrode configuration for one or a few pulses, followed by switching polarity back to the first electrode configuration. Information relating to the stimulation regimens may be used by the electrode polarity reversal unit 280 to control the operations of the first through nth switches 330(l-n).
In one embodiment, each of a plurality of stimulation regimens may respectively relate to a particular disorder. In one embodiment, different regimens relating to the same disorder may be implemented to accommodate improvements or regressions in the patient's present condition relative to his or her condition at previous times. By providing flexibility in electrode configurations nearly instantaneously, the present invention greatly expands the range of adjustments that may be made to respond to changes in the patient's underlying medical condition.
The switching controller 345 may be a processor that is capable of receiving data relating to the stimulation regimens. In an alternative embodiment, the switching controller
may be a software or a firmware module. Based upon the particulars of the stimulation regimens, the switching timing unit 333 may provide timing data to the switching controller 345. The first through nth switches 330(l-n) may be electrical devices, electro-mechanical devices, and/or solid state devices (e.g., transistors).
Figure 4 shows one embodiment of a method of performing changeable electrode polarity stimulation according to the present invention. In this embodiment, the IMD 200 has a first normal stimulation mode in which it performs single polarity stimulation 410, i.e., stimulation in which only one electrode 125 of the IMD 200 is the cathode for delivery of electrical signals to the cranial nerve, such as vagus nerve 127, and in which the electrode polarities are only changed by manual programming. At predetermined times during performance of single polarity stimulation 410, the IMD 200 checks 420 whether a signal to enter a changeable electrode polarity stimulation mode has been received. The signal to enter a changeable electrode polarity stimulation mode can be received, by way of nonlimiting examples, from the controller 210 (Figure 2), from a sensor or sensors implanted in or on the patient's body which detect(s) one or more bodily parameters (e.g., heart rate, respiration rate, blood pressure, blood glucose, etc.), from a medical practitioner communicating with the device via wand 155 (Figure 1), or a medical practitioner or patient using a magnet to provide a signal via the magnetic field detection unit 290. Regardless of the nature of the signal, if the IMD 200 does not detect it when checking 420, the IMD reverts to single polarity stimulation 410.
However, if the signal is received, the IMD 200 then implements a changeable electrode polarity stimulation mode shown in steps 430-460. Specifically, the IMD 200 delivers 430 a first predetermined number of pulses in a first polarity configuration of the
electrodes. For an example, a first electrode 125(1) may be the cathode and a second electrode 125(2) may be the anode in step 430. After the first predetermined number of pulses are delivered in the first polarity configuration (step 430), the IMD 200 reverses 440 the polarity of the electrodes to a second polarity configuration. Continuing the example, the first electrode 125(1) may be switched to be the anode and the second electrode 125(2) may be switched to be the cathode. It will be appreciated that, where 3 or more electrodes are used, only some of the electrode polarities may be reversed. Step 450 resembles step 430, though it will be noted the second polarity configuration differs from the first polarity configuration and the second predetermined number of pulses may differ in number of pulses or other stimulation parameters (pulse frequency, pulse width, On Time, Off Time, interpulse interval, number of pulses per burst, or interburst interval, among others) from the first predetermined number of pulses. Step 460 resembles step 440, though it will be noted it reverts the configuration of the electrodes to the first electrode polarity configuration as of step 430.
After steps 430-460 have been performed, the IMD 200 checks 470 whether a signal to discontinue the changeable electrode polarity stimulation mode has been received. The signal to discontinue the changeable electrode polarity stimulation mode can be received from the same sources described above in the context of checking step 420. Regardless of the nature of the signal, if the IMD 200 does not detect the signal when performing checking step 470, the IMD 200 continues changeable electrode polarity stimulation by returning to step 430. If the signal is detected when performing checking step 470, the IMD 200 reverts to single polarity stimulation 410.
Figure 5 shows another embodiment of a method according to the present invention.
The method comprises steps 530-560, which resemble steps 430-460 shown in Figure 4. The method shown in Figure 5 does not include single polarity stimulation; after the second reversal step 560 is performed, the IMD 200 continues changeable electrode polarity stimulation by returning to step 530.
In the methods shown in Figures 4-5, one or more of the properties of the first predetermined number of pulses (e.g., number of pulses, pulse frequency, pulse width, On Time, Off Time, interpulse interval, number of pulses per burst, or interburst interval, among others) can be changed upon each performance of step 430 or 530. The properties can be varied in a preprogrammed fashion, following programming executed by the controller 210, or can be varied according to data retrieved from a sensor of a bodily parameter of the patient or in response to instructions received from a medical practitioner or the patient. Similarly, one or more of the properties of the second predetermined number of pulses can be changed upon each performance of step 450 or 550.
Turning now to Figure 6, an exemplary configuration of the IMD 200 and electrodes being implemented in a patient's body, in accordance with an illustrative embodiment of the present invention, is provided. The IMD 200 provides therapeutic stimulation signals via the stimulation unit 220. The stimulation unit 220 provides signals via leads that are coupled to a first electrode 610 and a second electrode 620. The first and second electrodes 610, 620, may be coupled to a portion of a tissue in a patient. The diagram in Figure 6 depicts a tissue impedance experienced at the nodes of the first and second electrodes 610, 620. The tissue impedance 630 may generally be constant with slight variations based on bodily changes. For example, the tissue impedance may vary based upon hydration, pH changes, tissue
fibrosis around the electrodes, electrode polarization, electrode metal oxidation, scar tissue formation, injury, infection, inflammation, and other factors related to electrolyte balance, or two or more thereof. For example, the tissue impedance may vary based upon the acute-to- chronic transition from lead implant wherein the lead impedance may be 1800 Ohms soon after implant and 2800 Ohms a month after implant.
Upon delivery of an electrical pulse by the IMD 200, an electrical circuit path is completed, wherein a current (I) passes through the first electrode 610, through the tissue impedance 630, and through the second electrode 620. This results in a voltage (V) across the tissue impedance 630. The IMD 200 may also comprise a 1st capacitor (Cl) in series with the first electrode 610, as well as a 2nd capacitor (C2) in series with the second electrode 620. The 1st and 2nd capacitors Cl, C2 are provided for dissipating electrical charges built-up on the 1st and 2nd electrodes 610, 620 as a result of delivering therapeutic stimulation signals to the tissue impedance 630.
The diagram of Figure 6 also illustrates a first node (i.e., first anode) at the distal end of the electrode 610 and a second node (i.e., first cathode) at the distal end of the second electrode 620. The electrode polarity reversal unit 280 is capable of switching or reversing the polarity of the first and second electrodes to provide the changeable electrode polarity stimulation provided herein. In other words, the anode and cathode functions performed by the first and second nodes, respectively, may be reversed, wherein the first node transforms from being the anode to the cathode and the second node transforms from being the cathode to the anode.
Referring simultaneously to Figures 6 and 7A-7D, illustrative diagrams of an exemplary signal pulse and various resultant electrical parameters related to the circuit of
Figure 6, are provided. The 1st and 2nd capacitors Cl, C2 are capable of dissipating the charge build-up that results from the delivery of therapeutic electrical signal pulses to the tissue region represented by the tissue impedance 630. The stimulation unit 220 is capable of providing a controlled current signal that is exemplified in Figure 7A, which illustrates a current pulse signal. The delivery of the current illustrated in Figure 7A may result in a voltage, V, as illustrated in Figure 7B. The development of the voltage V as the current passes through the tissue impedance 630 is due to the flow of the current (I). Upon termination of the current pulse I, charge build-up is dissipated by the capacitors Cl and C2 at a rate defined by the time-constant (τ) of each capacitor Cl, C2. Therefore, the voltage across the capacitor Cl and C2, upon termination of the current I, will dissipate in an asymptotic fashion defined by the Equations 1 and 2:
Vfinai = Vinitia, * e'Λ ; Equation 1
T = R * C ; Equation 2
wherein Vfmal is the steady state voltage across each capacitor Cl and C2 after the current pulse (I) is terminated. The voltage, Vinj,jai, is the value of the voltage across Cl and C2 induced by the current pulse (I). The time-constant τ, defines the rate of decay (or rise) of the voltage across the capacitors Cl, C2. The time-constant τ, is defined by the capacitance value of C and the resistance experienced by the each capacitor Cl, C2. The charges built up in the capacitors Cl, C2, dissipate over time, resulting in a voltage rise from a negative level to zero in an asymptotic fashion as illustrated in Figure 7B.
Figure 7C illustrates the signal response relating to the capacitor Cl upon the delivery of the current I. Since instantaneous change in voltage is not possible across the capacitor
Cl, upon delivery of the current I, an asymptotic negative rise of voltage across Cl is realized. This voltage change is defined by the equation provided above. The voltage across the capacitor Cl is built up in the opposite polarity with reference to voltage V. Upon the termination of the pulse, the voltage stops increasing (in the negative direction) and asymptotically rises up to zero. Figure 7D illustrates that the capacitor C2 provides a rise in positive voltage in a similar manner. Upon termination of the current pulse I, the voltage across C2 decreases asymptotically to zero. Embodiments of the present invention provide for use of the remaining charges that may exist in the capacitors Cl and C2 and/or nodes of the electrodes, after the termination of an electrical signal pulse. These remaining charges may be used in the delivery of a subsequent electrical signal pulse. This may be achieved by reversing the polarities of the respective nodes of the first and second electrodes 610-620.
Figure 8 illustrates a second configuration of an exemplary implementation of the IMD 200, in which the polarity of the first and second electrodes have been reversed from those shown in Figure 6. In this configuration the first anode and the first cathode nodes have been reversed wherein the first anode of Figure 6 is now the second cathode of Figure 8, and the first cathode of Figure 6 is now the second anode of Figure 8. This reversal may be performed by the electrode polarity reversal unit 220 described above. Upon reversal of the nodes, the current I flows in the opposite direction upon application of a stimulation signal provided by the stimulation unit 220. Likewise, the voltage V across the tissue impedance 630 is also reversed. Reversal of the polarities may provide for various therapeutic benefits described above. This type of reversal may be provided during changeable electrode polarity stimulation, wherein the first and the second electrode 610, are configured in a bilateral fashion (i.e., wherein first electrode may be coupled to the right vagus nerve and the second electrode 620 may be coupled to the left vagus nerve, or vice versa). In an alternative
embodiment, the changeable electrode polarity system provided herein may be implemented in a unilateral configuration, such as both the first and second electrodes 610 and 620 being coupled to a single vagus nerve, such as the left vagus nerve.
In the unilateral configuration, the distance between the first and second electrodes 610, 620 may vary from 1 mm to 50 mm. For example, the electrodes may be spaced 1 cm apart for closely-spaced stimulation or 40 cm apart for distant stimulation. In an embodiment wherein the pulse generator case 121 is an electrode, the distance between an electrode 125 coupled to a cranial nerve and the pulse generator case 121 may vary from 1 mm to 300 mm.
Based upon the type of stimulation, the target tissue to be stimulated, and/or other factors, the distance between the electrodes 610, 620 may play a substantial part in targeting particular regions of a patient's body, in multiple directions. For example, the cathode may be placed strategically such that signals in both directions may propagate to a certain limit, such as to a particular plexus, and then would be blocked in one direction by the anode. In the opposite direction, a proximal cranium signal may be delivered to the brain.
Referring simultaneously to Figures 8 and Figures 9A-9D, illustrative diagrams of an exemplary signal pulse and various resultant electrical parameters related to the circuit of Figure 8, are provided. The stimulation unit 220 may provide a therapeutic electrical signal pulse having a programmed current. Due to the reversal of the cathode and the anode (in relation to the configuration of Figure 6), the stimulation current I is represented as going from zero to a negative value and back, in a pulse form, as illustrated in Figure 9A. During the duration of the current pulse (Figure 9A), the voltage V (Figure 9B) develops across the tissue impedance 630 (i.e., between the second cathode and the second anode) in the same
polarity as the current I. Upon termination of the current pulse I, the voltage is reversed due to the charges accumulated in the 1st and 2nd capacitors Cl, C2.
The configuration of Figure 8 causes the accumulation of voltage shown in Figure 9B to be in a negative direction compared to the configuration depicted and described in Figures 6 and 7. The discharge of the energy from the capacitors Cl and C2 provides for an asymptotic function of the voltage V as illustrated in Figure 9B. Figure 9C illustrates the signal-response in capacitor Cl to the electrical pulse shown in Figure 9 A. Upon assertion of the current pulse I, an asymptotical rise of voltage across the capacitor Cl in the opposite direction of the polarity of the current pulse I is produced. Similarly, an asymptotic rise in voltage in the negative direction (i.e., the same polarity of the current is generated) is produced across the capacitor C2.
Upon termination of the current pulse I, accumulated charges provide for an asymptotic decay of respective voltages across the capacitor Cl and C2, as illustrated in Figure 9C and 9D. Based upon the disclosure herein, those skilled in the art would not recognize that even after the termination of the current pulse I , there remains an electrical charge/energy accumulated on the capacitors Cl and C2. This charge/energy may be used to provide a subsequent pulse in the reverse polarity in a more efficient manner. In other words, using the accumulated charge/energy, which would otherwise have been simply dissipated, a subsequent stimulation pulse signal may be generated using less energy than otherwise would have been used. This is true because the remaining accumulated charges/energy (stored in the Cl and C2) may be "piggy backed" onto the driven constant current signal provided by the IMD 200 to reach the desired current amplitude based on using the electrical charge/energy that is stored in the capacitors Cl and C2.
This concept is further exemplified in an exemplary illustration provided in Figures 10A- 1OD which provide an exemplary illustration of accumulated charge/energy from one electrical signal pulse that may be used to generate a second electrical signal pulse. The solid lines in the diagrams of Figures 10A- 1OD represent the signals resulting from the delivery of an electrical signal pulse in the configuration illustrated in Figure 6. The signal responses indicated by the dotted lines represent signals resulting from the delivery of an electrical signal pulse performed after reversal of the first and second electrodes' polarities (as illustrated in Figure 8). Figures 10A- 1OD also define shaded regions that represents the charge/energy accumulated by a preceding therapeutic stimulation signal.
Referring simultaneously to Figures 6, 8 and 10A- 10D, Figure 1OA illustrates a first cathode signal response based upon the configuration of Figure 6 (i.e., with the first electrode as a first anode and the second electrode as a first cathode). The first cathode is coupled to the distal portion of the second electrode 620. When the stimulation unit 220 in Figure 6 applies an electrical signal current pulse, the resultant signal at the first cathode provides a signal that is opposite in polarity to the current I (Figure 10A). The capacitor C2, which in Figure 6 is a "cathode capacitor," provides an asymptotic rise in voltage until the termination of the current pulse, which then prompts an asymptotic decay (shaded region of Figure 10B) of the voltage.
Similarly, during the application of the current pulse I, the first anode, which is the output of the first electrode 610 in Figure 6, provides a signal with the same polarity as the current. An "anode capacitor" (Cl in the case of Figure 6) provides for an asymptotic negative rise in voltage, as illustrated in Figure 10D. Upon termination of the current pulse I, an asymptotic positive rise to zero voltage across the anode capacitor occurs (shaded region
of Figure 10D). Therefore, upon termination of the current pulse there remains a charge on the cathode capacitor (i.e., C2 in the configuration of Figure 6) and the anode capacitor (i.e., Cl in Figure 6). Both capacitors contain accumulated charge that may be discharged. The shaded regions in Figures 1OB and 1OD represent some lingering, accumulated charge/energy for a period of time, until they asymptotically decay.
However, if the polarity of the first anode and the first cathode are switched from the configuration of Figure 6 to the configuration of Figure 8, the accumulated charges in the capacitors Cl and C2 may be utilized in delivery of a subsequent electrical signal current pulse. If within the period of time in which there remains some charge/energy in the capacitors, as depicted by the shaded regions in Figures 1OB and 10D, an electrical signal current pulse delivered in those same directions (as the available charges/energy in Figure 1OB and 10D) would result in a boost in the signals delivered by the electrodes in the second configuration of Figure 8. This is illustrated by the dotted lines in Figure 1OA and 1OC. While an accumulated charge/energy still exists in the capacitors Cl and C2, as indicated in the shaded region of Figure 1OB and 10D, an electrode polarity reversal may be performed by the electrode polarity reversal unit 280. After reversing the polarity of the electrodes, the first cathode will become the second anode and the first anode will become the second cathode. In this manner, a pulse current signal in the opposite polarity is delivered, which would coincide with the polarity of the stored charges by the cathode capacitor and the anode capacitor.
As illustrated in Figure 1OA the second anode signal receives a charge boost for the portion of the pulse that overlaps the time period where there still remains stored charges/energy in the cathode capacitor. This is indicated by the shaded region ("second
anode charge boost") of Figure 1OA. Therefore, the stimulation unit 220 may generate and provide a smaller amount of energy to achieve a sufficient rise in the pulse current to obtain a desired amplitude because of the charge boost provided by the capacitor, as illustrated in Figure 1OA. Due to the feedback control current nature of the operation of the HMD 200, less charge proportionally is used than in cases where the charge on the capacitor completely decays, such that the second anode charge boost provides for a percentage of the total charge needed to provide the pulse illustrated in dotted lines in Figure 1OA.
Similarly, the second cathode also experiences a second cathode charge boost, as illustrated in Figure 1OC, due to the accumulated charge/energy remaining in the anode capacitor of Figure 10D. While an accumulated charge is present on the anode capacitor, a portion of the negative-polarity pulse is boosted by the existing charge on the anode capacitor. In this manner, leftover charges are utilized to provide energy for subsequent pulses. This may provide considerable savings in charge usage from the battery of the IMD 200. In this manner, the anode and cathode nodes may be reversed continuously (i.e., repeating the reversals several times) to take advantage of the existing charge from the previous delivery of a pulse, while delivering changeable electrode polarity stimulation, hi alternative embodiments, the polarity reversals of the cathode and the anode may only be performed periodically, hi such alternative embodiments, therefore, some resident charges may be dissipated by the capacitor Cl and C2 while some charges may be utilized during those times when the anode and the cathode nodes are reversed, hi this manner, substantial savings in charge-usage may be realized utilizing the changeable electrode polarity stimulation provided herein. In some cases, 80% or more of the electrical charge necessary for an electrical signal pulse may be provided by the energy stored in the capacitors. For the sake of clarity and ease of description, embodiments of the present invention were described
as in a two-electrode configuration. However, those skilled in the art having benefit of the present disclosure, would readily appreciate that a variety of configurations, with any number of electrodes, may be implemented and remain within the spirit and scope of the present invention. The above-described implementations may be provided in a bilateral configuration, as well as in a unilateral configuration. Therefore, utilizing the embodiments of the present invention, substantial appreciation in efficacy and power savings may be realized.
In one embodiment, a first electrode and a second electrode, substantially as described above, are directly coupled to a first ventricle of the heart and a second ventricle of the heart. This embodiment may realize substantial appreciation in efficacy, power savings, or both in a pacemaker device.
The particular embodiments disclosed above are illustrative only, as the invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Furthermore, no limitations are intended to the details of construction or design herein shown other than as described in the claims below. It is, therefore, evident that the particular embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the invention. Accordingly, the protection sought herein is as set forth in the claims below.
Claims
1. A method of treating a medical condition in a patient using an implantable medical device, comprising: coupling a first electrode to a first portion of a cranial nerve of the patient; coupling a second electrode to a second portion of the cranial nerve of the patient; providing a first electrical pulse to the first and second electrodes, wherein the first electrical pulse is provided in a first configuration in which the first electrode functions as an anode and the second electrode functions as a cathode, wherein upon termination of the first signal pulse, the anode and cathode each comprises an accumulated energy; and providing a second electrical pulse to the first and second electrodes, the second electrical pulse comprising at least a portion of the accumulated energy.
2. The method of claim 1, further comprising providing a second configuration of the electrodes upon termination of the first electrical pulse, wherein in the second configuration, the first electrode functions as a cathode and the second electrode functions as an anode.
3. The method of claim 2, wherein the implantable medical device is capable of providing a changeable electrode polarity stimulation based upon the first and second configurations.
4. The method of claim 1, wherein providing the first electrical pulse comprises providing a controlled current pulse based upon at least one predetermined parameter.
5. The method of claim 1, wherein providing the first electrical pulse comprises providing a feedback controlled current pulse capable of adjusting the amount of energy used based upon said accumulated energy.
6. The method of claim 5, further comprising reducing an amount of energy provided by a power source associated with the implantable medical device in providing said second electrical pulse, in response to detecting said accumulated energy.
7. The method of claim 2, further comprising changing the configuration of the first and second electrodes from the second configuration to the first configuration upon termination of the second electrical pulse, and providing a third electrical pulse, wherein the third electrical pulse comprises at least a portion of an accumulated energy resulting from said step of providing a second electrical pulse.
8. A method of treating a medical condition in a patient using an implantable medical device, comprising: providing a first electrical signal to a first electrode coupled to a first portion of a first electrically-stimulatable structure of the patient, and to a second electrode coupled to a second portion of a second electrically-stimulatable structure of the patient, wherein the first electrical signal is provided in a first polarity configuration in which the first electrode functions as an anode and the second electrode functions as a cathode, wherein the anode and cathode each comprises a first accumulated energy as a result of the first electrical signal; providing a second polarity configuration of the electrodes upon termination of the first electrical signal, wherein in the second polarity configuration, the first electrode functions as a cathode and the second electrode function as an anode; and providing a second electrical signal to the first and second electrodes in the second polarity configuration, the second electrical signal comprising at least a portion of the accumulated energy from the first electrical signal.
9. The method of claim 8, wherein the first electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart, and the second electrically-stimulatable structure is selected from the group consisting of the brain, the spinal cord, the peripheral nerves, and the heart.
10. The method of claim 9, wherein the cathode and anode each comprises a second accumulated energy as a result of the second electrical signal, further comprising changing the configuration of the first and second electrodes from the second polarity configuration to the first polarity configuration upon termination of the second electrical pulse, and providing a third electrical signal, wherein the third electrical signal comprises at least a portion of the second accumulated energy resulting from the second electrical signal.
11. The method of claim 9, wherein providing the first and second electrical signals comprises providing a feedback controlled current pulse capable of adjusting the amount of energy used based upon the first or second accumulated energy.
12. The method of claim 10, wherein the first electrical signal contains one pulse, the second electrical signal contains one pulse, and the third electrical signal contains one pulse.
13. The method of claim 10, wherein the first electrical signal contains a first number of pulses, the second electrical signal contains a second number of pulses, and the third electrical signal contains a third number of pulses, wherein the first number of pulses is not equal to the second number of pulses or the second number of pulses is not equal to the third number of pulses.
14. The method of claim 10, wherein the first electrical signal contains one or more bursts, the second electrical signal contains one or more bursts, and the third electrical signal contains one or more bursts.
15. The method of claim 10, wherein at least one of the first electrical signal, the second electrical signal, and the third electrical signal is characterized by having a number of pulses per microburst from 2 pulses to about 25 pulses, an interpulse interval from 2 msec to about 50 msec, an interburst period of at least 100 msec, and a microburst duration of less than about 1 sec.
16. The method of claim 9, wherein the medical condition is selected from the group consisting of depression, epilepsy, obesity, bulimia, traumatic brain injury, congestive heart failure, stroke, coma, fibromyalgia, addiction disorders, multiple sclerosis, haring disorder, Alzheimer's disease, Parkinson's disease, gastrointestinal disorders, pancreatic disorders, kidney disorders, and diabetes.
17. A method of treating a medical condition in a patient using an implantable medical device, comprising: coupling a first electrode to a portion of a right cranial nerve of the patient; coupling a second electrode to a portion of a left cranial nerve of the patient; providing a first electrical signal to the first and second electrodes, wherein the first electrical pulse is provided in a first polarity configuration in which the first electrode functions as an anode and the second electrode functions as a cathode, wherein upon termination of the first electrical, the anode and cathode each comprises a first accumulated energy; and providing a second polarity configuration of the electrodes upon termination of the first electrical signal, wherein in the second polarity configuration, the first electrode functions as a cathode and the second electrode function as an anode; and providing a second electrical signal to the first and second electrodes in the second polarity configuration, the second electrical signal comprising at least a portion of the first accumulated energy.
18. The method of claim 17, wherein coupling the first electrode to a portion of a right cranial nerve comprises coupling the first electrode to a portion of the right vagus nerve of the patient and coupling the second electrode to a portion of a left cranial nerve comprises coupling the second electrode to a portion of the left vagus nerve of the patient.
19. The method of claim 17, wherein the cathode and anode each comprises a second accumulated energy as a result the second electrical signal, further comprising changing the configuration of the first and second electrodes from the second polarity configuration to the first polarity configuration upon termination of the second electrical pulse, and providing a third electrical signal, wherein the third electrical signal comprises at least a portion of the second accumulated energy resulting from the second electrical pulse.
20. An implantable medical device for treating a medical condition in a patient, comprising: a controller capable of receiving data and controlling the operation of the implantable medical device by providing at least one control parameter; a stimulation unit for generating and delivering, based upon the at least one control parameter, a first electrical signal to a first electrode electrically coupled to a first portion of a cranial nerve and to a second electrode electrically coupled to a second portion of a cranial nerve, wherein the first electrical signal is provided in a first polarity configuration in which the first electrode functions as an anode and the second electrode functions as a cathode, wherein upon termination of the first electrical signal, the anode and cathode each comprises a first accumulated energy resulting from the first electrical signal; an electrode polarity reversal unit capable of changing the polarity configuration of the first and second electrodes from the first polarity configuration to a second polarity configuration in which the first electrode functions as a cathode and the second electrode function as an anode; and wherein the stimulation unit also provides a second electrical signal to the first and second electrodes in the second polarity configuration, wherein the second electrical signal comprises at least a portion of the first accumulated energy.
21. The implantable medical device of claim 20, wherein the electrode polarity reversal unit comprises: an electrode configuration switching unit comprising a switching controller; and a plurality of switches, wherein the switching controller is capable of controlling an operation of the switches to change the polarity configuration of the first and second electrodes from the first polarity configuration to the second polarity configuration, and from the second polarity configuration to the first polarity configuration.
22. The implantable medical device of claim 21, wherein the cathode and anode each comprises a second accumulated energy upon termination of the second electrical signal; wherein the electrode polarity reversal unit changes the polarity configuration of the first and second electrodes from the second polarity configuration to the first polarity configuration upon termination of the second electrical signal; and wherein the stimulation unit provides a third electrical signal to the first and second electrodes, wherein the third electrical signal comprises at least a portion of the second accumulated energy.
23. The implantable medical device of claim 20, further comprising a first capacitor in series with said first electrode and a second capacitor in series with the second electrode, the first and second capacitors to store charge as a result of the first and second electrical signals.
24. A computer readable program storage device encoded with instructions that, when executed by a computer, performs a method of treating a medical condition in a patient using an implantable medical device, comprising: providing a first electrical signal to a first electrode coupled to a first portion of a cranial nerve of the patient, and to a second electrode coupled to a second portion of a cranial nerve of the patient, wherein the first and second electrodes are provided in a first polarity configuration in which the first electrode functions as an anode and the second electrode functions as a cathode, wherein upon termination of the first electrical signal, the anode and cathode each comprises a first accumulated energy; providing a second polarity configuration of the electrodes upon termination of the first electrical signal, wherein in the second polarity configuration, the first electrode functions as a cathode and the second electrode function as an anode; and providing a second electrical signal to the first and second electrodes in the second polarity configuration, the second electrical signal comprising at least a portion of the first accumulated energy.
25. The computer readable program storage device encoded with instructions that, when executed by a computer, performs the method of claim 24, wherein upon termination of the second electrical signal the cathode and anode each comprises a second accumulated energy, further comprising changing the polarity configuration of the first and second electrodes from the second polarity configuration to the first polarity configuration upon termination of the second electrical pulse, and providing a third electrical signal, wherein the third electrical signal comprises at least a portion of the second accumulated energy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/020,195 | 2008-01-25 | ||
US12/020,195 US8260426B2 (en) | 2008-01-25 | 2008-01-25 | Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009102393A1 true WO2009102393A1 (en) | 2009-08-20 |
Family
ID=40474693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/000386 WO2009102393A1 (en) | 2008-01-25 | 2009-01-22 | Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device |
Country Status (2)
Country | Link |
---|---|
US (1) | US8260426B2 (en) |
WO (1) | WO2009102393A1 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7167750B2 (en) | 2003-02-03 | 2007-01-23 | Enteromedics, Inc. | Obesity treatment with electrically induced vagal down regulation |
US7844338B2 (en) | 2003-02-03 | 2010-11-30 | Enteromedics Inc. | High frequency obesity treatment |
US20040172084A1 (en) | 2003-02-03 | 2004-09-02 | Knudson Mark B. | Method and apparatus for treatment of gastro-esophageal reflux disease (GERD) |
US9314633B2 (en) | 2008-01-25 | 2016-04-19 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US11331488B2 (en) | 2007-03-09 | 2022-05-17 | Mainstay Medical Limited | Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention |
US9072897B2 (en) | 2007-03-09 | 2015-07-07 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine |
US11679261B2 (en) | 2007-03-09 | 2023-06-20 | Mainstay Medical Limited | Systems and methods for enhancing function of spine stabilization muscles associated with a spine surgery intervention |
US10925637B2 (en) | 2010-03-11 | 2021-02-23 | Mainstay Medical Limited | Methods of implanting electrode leads for use with implantable neuromuscular electrical stimulator |
US8068918B2 (en) | 2007-03-09 | 2011-11-29 | Enteromedics Inc. | Remote monitoring and control of implantable devices |
US11679262B2 (en) | 2007-03-09 | 2023-06-20 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine |
US8428728B2 (en) | 2007-03-09 | 2013-04-23 | Mainstay Medical Limited | Muscle stimulator |
US20080281365A1 (en) * | 2007-05-09 | 2008-11-13 | Tweden Katherine S | Neural signal duty cycle |
US8140167B2 (en) | 2007-05-31 | 2012-03-20 | Enteromedics, Inc. | Implantable therapy system with external component having multiple operating modes |
US9579506B2 (en) * | 2008-01-25 | 2017-02-28 | Flint Hills Scientific, L.L.C. | Contingent cardio-protection for epilepsy patients |
US9186502B2 (en) * | 2008-02-14 | 2015-11-17 | Enteromedics Inc. | Treatment of excess weight by neural downregulation in combination with compositions |
EP3047874B1 (en) | 2008-04-04 | 2022-03-09 | ReShape Lifesciences Inc. | Systems for glucose regulation and methods of making such systems |
US8768469B2 (en) | 2008-08-08 | 2014-07-01 | Enteromedics Inc. | Systems for regulation of blood pressure and heart rate |
US9895530B2 (en) | 2008-12-05 | 2018-02-20 | Spr Therapeutics, Inc. | Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain |
US11684774B2 (en) | 2010-03-11 | 2023-06-27 | Mainstay Medical Limited | Electrical stimulator for treatment of back pain and methods of use |
CN103079633B (en) | 2010-03-11 | 2016-05-04 | 梅恩斯塔伊医疗公司 | Be used for the treatment of modular stimulator, implanted RF ablation system and the using method of backache |
US9999763B2 (en) | 2012-06-13 | 2018-06-19 | Mainstay Medical Limited | Apparatus and methods for anchoring electrode leads adjacent to nervous tissue |
US9950159B2 (en) | 2013-10-23 | 2018-04-24 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same |
US11786725B2 (en) | 2012-06-13 | 2023-10-17 | Mainstay Medical Limited | Systems and methods for restoring muscle function to the lumbar spine and kits for implanting the same |
US8825164B2 (en) | 2010-06-11 | 2014-09-02 | Enteromedics Inc. | Neural modulation devices and methods |
US8768453B2 (en) | 2010-10-13 | 2014-07-01 | Boston Scientific Neuromodulation Corporation | Monitoring electrode voltages in an implantable medical device system having daisy-chained electrode-driver integrated circuits |
AU2015227500B2 (en) * | 2010-10-13 | 2017-06-01 | Boston Scientific Neuromdulaton Corporation | Monitoring electrode voltages in an implantable medical device system having daisy-chained electrode-driver integrated circuits |
US8788046B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
US8788048B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
US8788047B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
CA2848054C (en) * | 2011-09-06 | 2022-11-08 | Spr Therapeutics, Llc | Systems and methods to place one or more leads in tissue to electrically stimulate nerves of passage to treat pain |
EP3115080A1 (en) | 2012-03-09 | 2017-01-11 | Enteromedics Inc. | Safety features for use in medical devices |
US10195419B2 (en) | 2012-06-13 | 2019-02-05 | Mainstay Medical Limited | Electrode leads for use with implantable neuromuscular electrical stimulator |
US9186501B2 (en) | 2012-06-13 | 2015-11-17 | Mainstay Medical Limited | Systems and methods for implanting electrode leads for use with implantable neuromuscular electrical stimulator |
US9694181B2 (en) * | 2012-06-15 | 2017-07-04 | Case Western Reserve University | Methods of treatment of a neurological disorder using electrical nerve conduction block |
US10195434B2 (en) | 2012-06-15 | 2019-02-05 | Case Western Reserve University | Treatment of pain using electrical nerve conduction block |
US9387322B2 (en) | 2012-06-15 | 2016-07-12 | Case Western Reserve University | Therapy delivery devices and methods for non-damaging neural tissue conduction block |
WO2014035796A1 (en) * | 2012-08-31 | 2014-03-06 | Flint Hills Scientific, Llc | Contingent cardio-protection for epilepsy patients |
US20140276551A1 (en) * | 2013-03-15 | 2014-09-18 | Flint Hills Scientific, L.L.C. | Epileptic seizure therapies comprising partial reduction or cooling of blood flow to brain regions |
US20150238764A1 (en) | 2013-05-10 | 2015-08-27 | Case Western Reserve University | Systems and methods for preventing noise in an electric waveform for neural stimulation, block, or sensing |
US10471268B2 (en) | 2014-10-16 | 2019-11-12 | Mainstay Medical Limited | Systems and methods for monitoring muscle rehabilitation |
US10765863B2 (en) | 2015-02-24 | 2020-09-08 | Elira, Inc. | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
US10335302B2 (en) | 2015-02-24 | 2019-07-02 | Elira, Inc. | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
US9956393B2 (en) | 2015-02-24 | 2018-05-01 | Elira, Inc. | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
US10864367B2 (en) | 2015-02-24 | 2020-12-15 | Elira, Inc. | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
US10376145B2 (en) | 2015-02-24 | 2019-08-13 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
EP3261712B1 (en) | 2015-02-24 | 2024-04-03 | Elira, Inc. | System for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
US10828485B2 (en) | 2015-10-06 | 2020-11-10 | Case Western Reserve University | High-charge capacity electrodes to deliver direct current nerve conduction block |
US10864373B2 (en) | 2015-12-15 | 2020-12-15 | Case Western Reserve University | Systems for treatment of a neurological disorder using electrical nerve conduction block |
US10327810B2 (en) | 2016-07-05 | 2019-06-25 | Mainstay Medical Limited | Systems and methods for enhanced implantation of electrode leads between tissue layers |
WO2018039670A1 (en) | 2016-08-26 | 2018-03-01 | Spr Therapeutics, Llc | Devices and methods for delivery of electrical current for pain relief |
US11540973B2 (en) | 2016-10-21 | 2023-01-03 | Spr Therapeutics, Llc | Method and system of mechanical nerve stimulation for pain relief |
EP3606599A4 (en) | 2017-04-03 | 2021-01-13 | Presidio Medical, Inc. | Systems and methods for direct current nerve conduction block |
WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
WO2019133997A1 (en) | 2017-12-31 | 2019-07-04 | Neuroenhancement Lab, LLC | System and method for neuroenhancement to enhance emotional response |
ES2947433T3 (en) | 2018-02-20 | 2023-08-09 | Presidio Medical Inc | Nerve conduction block systems |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
EP3813925A4 (en) | 2018-07-01 | 2022-04-13 | Presidio Medical, Inc. | Systems and methods for nerve conduction block |
EP3849410A4 (en) | 2018-09-14 | 2022-11-02 | Neuroenhancement Lab, LLC | System and method of improving sleep |
EP4061476A4 (en) | 2019-11-24 | 2023-12-13 | Presidio Medical, Inc. | Pulse generation and stimulation engine systems |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007018793A1 (en) * | 2005-07-29 | 2007-02-15 | Cyberonics, Inc. | Medical devices and methods for enhancing intrinsic neural activity |
US20070203521A1 (en) * | 2002-03-22 | 2007-08-30 | Leptos Biomedical, Inc. | Nerve stimulation for treatment of obesity, metabolic syndrome, and type 2 diabetes |
Family Cites Families (391)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US233193A (en) | 1880-10-12 | And rufus e | ||
US3760812A (en) | 1971-03-19 | 1973-09-25 | Univ Minnesota | Implantable spiral wound stimulation electrodes |
US3796221A (en) | 1971-07-07 | 1974-03-12 | N Hagfors | Apparatus for delivering electrical stimulation energy to body-implanted apparatus with signal-receiving means |
US4107469A (en) | 1977-02-17 | 1978-08-15 | Rockwell International Corporation | Multiplex/demultiplex apparatus |
JPS54119792A (en) | 1978-03-03 | 1979-09-17 | Iriyou Kougaku Kenkiyuushiyo K | Electric stimulation device for removing pain |
IT1118131B (en) | 1978-07-20 | 1986-02-24 | Medtronic Inc | IMPROVEMENT IN MULTI-MODE CARDIAC PACEMAKERS ADAPTABLE IMPLANTABLE |
US4431000A (en) | 1978-11-29 | 1984-02-14 | Gatron Corporation | Transcutaneous nerve stimulator with pseusorandom pulse generator |
US4503863A (en) | 1979-06-29 | 1985-03-12 | Katims Jefferson J | Method and apparatus for transcutaneous electrical stimulation |
US4305402A (en) | 1979-06-29 | 1981-12-15 | Katims Jefferson J | Method for transcutaneous electrical stimulation |
US4424812A (en) | 1980-10-09 | 1984-01-10 | Cordis Corporation | Implantable externally programmable microprocessor-controlled tissue stimulator |
US4612934A (en) | 1981-06-30 | 1986-09-23 | Borkan William N | Non-invasive multiprogrammable tissue stimulator |
US4793353A (en) | 1981-06-30 | 1988-12-27 | Borkan William N | Non-invasive multiprogrammable tissue stimulator and method |
US4459989A (en) | 1981-06-30 | 1984-07-17 | Neuromed, Inc. | Non-invasive multiprogrammable tissue stimulator and methods for use |
US4606349A (en) | 1981-08-10 | 1986-08-19 | Cordis Corporation | Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability |
US4625308A (en) | 1982-11-30 | 1986-11-25 | American Satellite Company | All digital IDMA dynamic channel allocated satellite communications system and method |
CA1215128A (en) | 1982-12-08 | 1986-12-09 | Pedro Molina-Negro | Electric nerve stimulator device |
US4867164A (en) | 1983-09-14 | 1989-09-19 | Jacob Zabara | Neurocybernetic prosthesis |
US4702254A (en) | 1983-09-14 | 1987-10-27 | Jacob Zabara | Neurocybernetic prosthesis |
US5025807A (en) | 1983-09-14 | 1991-06-25 | Jacob Zabara | Neurocybernetic prosthesis |
US4577316A (en) | 1984-02-13 | 1986-03-18 | Rca Corporation | Synchronization system for a regenerative subtransponder satellite communication system |
US4590946A (en) | 1984-06-14 | 1986-05-27 | Biomed Concepts, Inc. | Surgically implantable electrode for nerve bundles |
US4573481A (en) | 1984-06-25 | 1986-03-04 | Huntington Institute Of Applied Research | Implantable electrode array |
US4649936A (en) | 1984-10-11 | 1987-03-17 | Case Western Reserve University | Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking |
US4628942A (en) | 1984-10-11 | 1986-12-16 | Case Western Reserve University | Asymmetric shielded two electrode cuff |
US4608985A (en) | 1984-10-11 | 1986-09-02 | Case Western Reserve University | Antidromic pulse generating wave form for collision blocking |
US4592339A (en) | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
GB8813518D0 (en) | 1988-06-08 | 1988-07-13 | Dunlop Ltd | Improvements in multi-disc brakes |
US4949721A (en) | 1988-08-11 | 1990-08-21 | Omron Tateisi Electronics Co. | Transcutaneous electric nerve stimulater |
US4920979A (en) | 1988-10-12 | 1990-05-01 | Huntington Medical Research Institute | Bidirectional helical electrode for nerve stimulation |
DE58907785D1 (en) | 1989-03-13 | 1994-07-07 | Siemens Ag | Implantable medical device for stimulating a physiological process of a living being with stimulation intensity that can be adapted to the physical activity of the living being. |
US5210854A (en) | 1989-06-14 | 1993-05-11 | Digital Equipment Corporation | System for updating program stored in eeprom by storing new version into new location and updating second transfer vector to contain starting address of new version |
US5522865A (en) | 1989-09-22 | 1996-06-04 | Alfred E. Mann Foundation For Scientific Research | Voltage/current control system for a human tissue stimulator |
US4979511A (en) | 1989-11-03 | 1990-12-25 | Cyberonics, Inc. | Strain relief tether for implantable electrode |
US5235980A (en) | 1989-11-13 | 1993-08-17 | Cyberonics, Inc. | Implanted apparatus disabling switching regulator operation to allow radio frequency signal reception |
US5186170A (en) | 1989-11-13 | 1993-02-16 | Cyberonics, Inc. | Simultaneous radio frequency and magnetic field microprocessor reset circuit |
US5154172A (en) | 1989-11-13 | 1992-10-13 | Cyberonics, Inc. | Constant current sources with programmable voltage source |
US5179950A (en) | 1989-11-13 | 1993-01-19 | Cyberonics, Inc. | Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not providing stimulation |
US5263480A (en) | 1991-02-01 | 1993-11-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5188104A (en) | 1991-02-01 | 1993-02-23 | Cyberonics, Inc. | Treatment of eating disorders by nerve stimulation |
US5269303A (en) | 1991-02-22 | 1993-12-14 | Cyberonics, Inc. | Treatment of dementia by nerve stimulation |
US5215086A (en) | 1991-05-03 | 1993-06-01 | Cyberonics, Inc. | Therapeutic treatment of migraine symptoms by stimulation |
US5335657A (en) | 1991-05-03 | 1994-08-09 | Cyberonics, Inc. | Therapeutic treatment of sleep disorder by nerve stimulation |
US5299569A (en) | 1991-05-03 | 1994-04-05 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by nerve stimulation |
US5205285A (en) | 1991-06-14 | 1993-04-27 | Cyberonics, Inc. | Voice suppression of vagal stimulation |
US5222494A (en) | 1991-07-31 | 1993-06-29 | Cyberonics, Inc. | Implantable tissue stimulator output stabilization system |
US5231988A (en) | 1991-08-09 | 1993-08-03 | Cyberonics, Inc. | Treatment of endocrine disorders by nerve stimulation |
WO1993002744A1 (en) | 1991-08-09 | 1993-02-18 | Cyberonics, Inc. | Treatment of anxiety disorders by nerve stimulation |
US5354320A (en) | 1991-09-12 | 1994-10-11 | Biotronik Mess- Und Therapiegerate Gmbh & Co., Ingenieurburo Berlin | Neurostimulator for production of periodic stimulation pulses |
IT1259358B (en) | 1992-03-26 | 1996-03-12 | Sorin Biomedica Spa | IMPLANTABLE DEVICE FOR DETECTION AND CONTROL OF THE SYMPATHIC-VAGAL TONE |
US5330507A (en) | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
GB9211085D0 (en) | 1992-05-23 | 1992-07-08 | Tippey Keith E | Electrical stimulation |
IT1260485B (en) | 1992-05-29 | 1996-04-09 | PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT | |
US5330515A (en) | 1992-06-17 | 1994-07-19 | Cyberonics, Inc. | Treatment of pain by vagal afferent stimulation |
EP0647151B1 (en) | 1992-06-30 | 1997-01-15 | Medtronic, Inc. | Apparatus for treatment of angina |
WO1994017771A2 (en) | 1993-02-10 | 1994-08-18 | Siemens Aktiengesellschaft | Process and apparatus for analgesic therapy and/or for influencing the vegetative nervous system |
US5411540A (en) | 1993-06-03 | 1995-05-02 | Massachusetts Institute Of Technology | Method and apparatus for preferential neuron stimulation |
US5540736A (en) * | 1993-08-02 | 1996-07-30 | Haimovich; Yechiel | Transcranial electrostimulation apparatus having two electrode pairs and independent current generators |
US5411531A (en) | 1993-09-23 | 1995-05-02 | Medtronic, Inc. | Method and apparatus for control of A-V interval |
EP0688578B1 (en) | 1994-06-24 | 1999-11-10 | Pacesetter AB | Arrhythmia detector |
US5531778A (en) | 1994-09-20 | 1996-07-02 | Cyberonics, Inc. | Circumneural electrode assembly |
US5522862A (en) | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
US5540734A (en) | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US5647379A (en) | 1994-11-22 | 1997-07-15 | Ventritex, Inc. | Correlator based electromagnetic interference responsive control system useful in medical devices |
US6425852B1 (en) | 1994-11-28 | 2002-07-30 | Emory University | Apparatus and method for transcranial magnetic brain stimulation, including the treatment of depression and the localization and characterization of speech arrest |
US6132361A (en) | 1994-11-28 | 2000-10-17 | Neotonus, Inc. | Transcranial brain stimulation |
US5571150A (en) | 1994-12-19 | 1996-11-05 | Cyberonics, Inc. | Treatment of patients in coma by nerve stimulation |
US5601617A (en) | 1995-04-26 | 1997-02-11 | Advanced Bionics Corporation | Multichannel cochlear prosthesis with flexible control of stimulus waveforms |
US6219580B1 (en) | 1995-04-26 | 2001-04-17 | Advanced Bionics Corporation | Multichannel cochlear prosthesis with flexible control of stimulus waveforms |
US5540730A (en) | 1995-06-06 | 1996-07-30 | Cyberonics, Inc. | Treatment of motility disorders by nerve stimulation |
US5707400A (en) | 1995-09-19 | 1998-01-13 | Cyberonics, Inc. | Treating refractory hypertension by nerve stimulation |
US5700282A (en) | 1995-10-13 | 1997-12-23 | Zabara; Jacob | Heart rhythm stabilization using a neurocybernetic prosthesis |
US6944501B1 (en) | 2000-04-05 | 2005-09-13 | Neurospace, Inc. | Neurostimulator involving stimulation strategies and process for using it |
US6480743B1 (en) | 2000-04-05 | 2002-11-12 | Neuropace, Inc. | System and method for adaptive brain stimulation |
US5755750A (en) | 1995-11-13 | 1998-05-26 | University Of Florida | Method and apparatus for selectively inhibiting activity in nerve fibers |
US5995868A (en) | 1996-01-23 | 1999-11-30 | University Of Kansas | System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject |
US6463328B1 (en) | 1996-02-02 | 2002-10-08 | Michael Sasha John | Adaptive brain stimulation method and system |
US5611350A (en) | 1996-02-08 | 1997-03-18 | John; Michael S. | Method and apparatus for facilitating recovery of patients in deep coma |
US5913876A (en) | 1996-02-20 | 1999-06-22 | Cardiothoracic Systems, Inc. | Method and apparatus for using vagus nerve stimulation in surgery |
US5651378A (en) | 1996-02-20 | 1997-07-29 | Cardiothoracic Systems, Inc. | Method of using vagal nerve stimulation in surgery |
US6051017A (en) | 1996-02-20 | 2000-04-18 | Advanced Bionics Corporation | Implantable microstimulator and systems employing the same |
US5690681A (en) | 1996-03-29 | 1997-11-25 | Purdue Research Foundation | Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation |
UA48221C2 (en) | 1996-04-01 | 2002-08-15 | Валєрій Івановіч Кобозєв | Electrical gastro-intestinal tract stimulator |
US5702429A (en) | 1996-04-04 | 1997-12-30 | Medtronic, Inc. | Neural stimulation techniques with feedback |
US6628987B1 (en) | 2000-09-26 | 2003-09-30 | Medtronic, Inc. | Method and system for sensing cardiac contractions during vagal stimulation-induced cardiopalegia |
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6532388B1 (en) | 1996-04-30 | 2003-03-11 | Medtronic, Inc. | Method and system for endotracheal/esophageal stimulation prior to and during a medical procedure |
US5690691A (en) | 1996-05-08 | 1997-11-25 | The Center For Innovative Technology | Gastro-intestinal pacemaker having phased multi-point stimulation |
AU3304997A (en) | 1996-05-31 | 1998-01-05 | Southern Illinois University | Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation |
US6609031B1 (en) | 1996-06-07 | 2003-08-19 | Advanced Neuromodulation Systems, Inc. | Multiprogrammable tissue stimulator and method |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5800474A (en) | 1996-11-01 | 1998-09-01 | Medtronic, Inc. | Method of controlling epilepsy by brain stimulation |
US5690688A (en) | 1996-11-12 | 1997-11-25 | Pacesetter Ab | Medical therapy apparatus which administers therapy adjusted to follow natural variability of the physiological function being controlled |
AR010696A1 (en) | 1996-12-12 | 2000-06-28 | Sasol Tech Pty Ltd | A METHOD FOR THE ELIMINATION OF CARBON DIOXIDE FROM A PROCESS GAS |
US7630757B2 (en) | 1997-01-06 | 2009-12-08 | Flint Hills Scientific Llc | System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject |
US6026326A (en) | 1997-01-13 | 2000-02-15 | Medtronic, Inc. | Apparatus and method for treating chronic constipation |
AU6667698A (en) | 1997-02-26 | 1998-09-18 | Alfred E. Mann Foundation For Scientific Research | Battery-powered patient implantable device |
US5792212A (en) | 1997-03-07 | 1998-08-11 | Medtronic, Inc. | Nerve evoked potential measurement system using chaotic sequences for noise rejection |
US5836994A (en) | 1997-04-30 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for electrical stimulation of the gastrointestinal tract |
US5861014A (en) | 1997-04-30 | 1999-01-19 | Medtronic, Inc. | Method and apparatus for sensing a stimulating gastrointestinal tract on-demand |
IT1292016B1 (en) | 1997-05-28 | 1999-01-25 | Valerio Cigaina | IMPLANT DEVICE PARTICULARLY FOR ELECTROSTIMULATION AND / OR ELECTRO-REGISTRATION OF ENDOABDOMINAL VISCERS |
CA2300049C (en) | 1997-08-08 | 2009-03-10 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
US6479523B1 (en) | 1997-08-26 | 2002-11-12 | Emory University | Pharmacologic drug combination in vagal-induced asystole |
US6141590A (en) | 1997-09-25 | 2000-10-31 | Medtronic, Inc. | System and method for respiration-modulated pacing |
US6409674B1 (en) | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US5941906A (en) | 1997-10-15 | 1999-08-24 | Medtronic, Inc. | Implantable, modular tissue stimulator |
US6016449A (en) | 1997-10-27 | 2000-01-18 | Neuropace, Inc. | System for treatment of neurological disorders |
US6459936B2 (en) | 1997-10-27 | 2002-10-01 | Neuropace, Inc. | Methods for responsively treating neurological disorders |
US6104955A (en) | 1997-12-15 | 2000-08-15 | Medtronic, Inc. | Method and apparatus for electrical stimulation of the gastrointestinal tract |
US6078838A (en) | 1998-02-13 | 2000-06-20 | University Of Iowa Research Foundation | Pseudospontaneous neural stimulation system and method |
US6221908B1 (en) | 1998-03-12 | 2001-04-24 | Scientific Learning Corporation | System for stimulating brain plasticity |
US6374140B1 (en) | 1998-04-30 | 2002-04-16 | Medtronic, Inc. | Method and apparatus for treating seizure disorders by stimulating the olfactory senses |
US5928272A (en) | 1998-05-02 | 1999-07-27 | Cyberonics, Inc. | Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity |
US6463327B1 (en) | 1998-06-11 | 2002-10-08 | Cprx Llc | Stimulatory device and methods to electrically stimulate the phrenic nerve |
US8762065B2 (en) | 1998-08-05 | 2014-06-24 | Cyberonics, Inc. | Closed-loop feedback-driven neuromodulation |
US7747325B2 (en) | 1998-08-05 | 2010-06-29 | Neurovista Corporation | Systems and methods for monitoring a patient's neurological disease state |
US9375573B2 (en) | 1998-08-05 | 2016-06-28 | Cyberonics, Inc. | Systems and methods for monitoring a patient's neurological disease state |
US7209787B2 (en) | 1998-08-05 | 2007-04-24 | Bioneuronics Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US6366813B1 (en) | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US7242984B2 (en) | 1998-08-05 | 2007-07-10 | Neurovista Corporation | Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease |
US9320900B2 (en) | 1998-08-05 | 2016-04-26 | Cyberonics, Inc. | Methods and systems for determining subject-specific parameters for a neuromodulation therapy |
US7231254B2 (en) | 1998-08-05 | 2007-06-12 | Bioneuronics Corporation | Closed-loop feedback-driven neuromodulation |
US6249704B1 (en) | 1998-08-11 | 2001-06-19 | Advanced Bionics Corporation | Low voltage stimulation to elicit stochastic response patterns that enhance the effectiveness of a cochlear implant |
US6366814B1 (en) | 1998-10-26 | 2002-04-02 | Birinder R. Boveja | External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders |
US6269270B1 (en) | 1998-10-26 | 2001-07-31 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator |
US6615081B1 (en) | 1998-10-26 | 2003-09-02 | Birinder R. Boveja | Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator |
US6505074B2 (en) | 1998-10-26 | 2003-01-07 | Birinder R. Boveja | Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator |
US6668191B1 (en) | 1998-10-26 | 2003-12-23 | Birinder R. Boveja | Apparatus and method for electrical stimulation adjunct (add-on) therapy of atrial fibrillation, inappropriate sinus tachycardia, and refractory hypertension with an external stimulator |
US6356788B2 (en) | 1998-10-26 | 2002-03-12 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy for depression, migraine, neuropsychiatric disorders, partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
US6611715B1 (en) | 1998-10-26 | 2003-08-26 | Birinder R. Boveja | Apparatus and method for neuromodulation therapy for obesity and compulsive eating disorders using an implantable lead-receiver and an external stimulator |
US6564102B1 (en) | 1998-10-26 | 2003-05-13 | Birinder R. Boveja | Apparatus and method for adjunct (add-on) treatment of coma and traumatic brain injury with neuromodulation using an external stimulator |
US6253109B1 (en) | 1998-11-05 | 2001-06-26 | Medtronic Inc. | System for optimized brain stimulation |
US6161044A (en) | 1998-11-23 | 2000-12-12 | Synaptic Corporation | Method and apparatus for treating chronic pain syndromes, tremor, dementia and related disorders and for inducing electroanesthesia using high frequency, high intensity transcutaneous electrical nerve stimulation |
US6155267A (en) | 1998-12-31 | 2000-12-05 | Medtronic, Inc. | Implantable medical device monitoring method and system regarding same |
US6324421B1 (en) | 1999-03-29 | 2001-11-27 | Medtronic, Inc. | Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same |
US6115628A (en) | 1999-03-29 | 2000-09-05 | Medtronic, Inc. | Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals |
US6895278B1 (en) | 1999-04-14 | 2005-05-17 | Transneuronix, Inc. | Gastric stimulator apparatus and method for use |
US6684104B2 (en) | 1999-04-14 | 2004-01-27 | Transneuronix, Inc. | Gastric stimulator apparatus and method for installing |
US6190324B1 (en) | 1999-04-28 | 2001-02-20 | Medtronic, Inc. | Implantable medical device for tracking patient cardiac status |
US6579280B1 (en) | 1999-04-30 | 2003-06-17 | Medtronic, Inc. | Generic multi-step therapeutic treatment protocol |
US6341236B1 (en) | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
US6353762B1 (en) | 1999-04-30 | 2002-03-05 | Medtronic, Inc. | Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve |
US6312378B1 (en) | 1999-06-03 | 2001-11-06 | Cardiac Intelligence Corporation | System and method for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6167311A (en) | 1999-06-14 | 2000-12-26 | Electro Core Techniques, Llc | Method of treating psychological disorders by brain stimulation within the thalamus |
US7454359B2 (en) | 1999-06-23 | 2008-11-18 | Visicu, Inc. | System and method for displaying a health status of hospitalized patients |
US7991625B2 (en) | 1999-06-23 | 2011-08-02 | Koninklijke Philips Electronics N.V. | System for providing expert care to a basic care medical facility from a remote location |
US6587719B1 (en) * | 1999-07-01 | 2003-07-01 | Cyberonics, Inc. | Treatment of obesity by bilateral vagus nerve stimulation |
US6188929B1 (en) | 1999-07-15 | 2001-02-13 | Joseph Giordano | Sequentially generated multi-parameter bio-electric delivery system and method |
US6298271B1 (en) | 1999-07-19 | 2001-10-02 | Medtronic, Inc. | Medical system having improved telemetry |
US6820019B1 (en) | 1999-07-31 | 2004-11-16 | Medtronic, Inc. | Device and method for determining and communicating the remaining life of a battery in an implantable neurological tissue stimulating device |
US6304775B1 (en) | 1999-09-22 | 2001-10-16 | Leonidas D. Iasemidis | Seizure warning and prediction |
US6308102B1 (en) | 1999-09-29 | 2001-10-23 | Stimsoft, Inc. | Patient interactive neurostimulation system and method |
US6381496B1 (en) | 1999-10-01 | 2002-04-30 | Advanced Bionics Corporation | Parameter context switching for an implanted device |
US6560486B1 (en) | 1999-10-12 | 2003-05-06 | Ivan Osorio | Bi-directional cerebral interface system |
US6473644B1 (en) | 1999-10-13 | 2002-10-29 | Cyberonics, Inc. | Method to enhance cardiac capillary growth in heart failure patients |
US6764498B2 (en) | 1999-12-09 | 2004-07-20 | Hans Alois Mische | Methods and devices for treatment of neurological disorders |
US6853862B1 (en) | 1999-12-03 | 2005-02-08 | Medtronic, Inc. | Gastroelectric stimulation for influencing pancreatic secretions |
EP1244496A1 (en) | 1999-12-17 | 2002-10-02 | Advanced Bionics Corporation | Magnitude programming for implantable electrical stimulator |
US20050240246A1 (en) | 1999-12-24 | 2005-10-27 | Medtronic, Inc. | Large-scale processing loop for implantable medical devices |
US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
US20060085046A1 (en) | 2000-01-20 | 2006-04-20 | Ali Rezai | Methods of treating medical conditions by transvascular neuromodulation of the autonomic nervous system |
US6438423B1 (en) | 2000-01-20 | 2002-08-20 | Electrocore Technique, Llc | Method of treating complex regional pain syndromes by electrical stimulation of the sympathetic nerve chain |
US6600953B2 (en) | 2000-12-11 | 2003-07-29 | Impulse Dynamics N.V. | Acute and chronic electrical signal therapy for obesity |
DE10002932A1 (en) | 2000-01-25 | 2001-07-26 | Biotronik Mess & Therapieg | Medical device implant |
US6609030B1 (en) | 2000-02-24 | 2003-08-19 | Electrocore Techniques, Llc | Method of treating psychiatric diseases by neuromodulation within the dorsomedial thalamus |
US6418344B1 (en) | 2000-02-24 | 2002-07-09 | Electrocore Techniques, Llc | Method of treating psychiatric disorders by electrical stimulation within the orbitofrontal cerebral cortex |
US6708064B2 (en) | 2000-02-24 | 2004-03-16 | Ali R. Rezai | Modulation of the brain to affect psychiatric disorders |
US6473639B1 (en) | 2000-03-02 | 2002-10-29 | Neuropace, Inc. | Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures |
US6484132B1 (en) | 2000-03-07 | 2002-11-19 | Lockheed Martin Energy Research Corporation | Condition assessment of nonlinear processes |
US6612983B1 (en) | 2000-03-28 | 2003-09-02 | Medtronic, Inc. | Pancreatic secretion response to stimulation test protocol |
US6768969B1 (en) | 2000-04-03 | 2004-07-27 | Flint Hills Scientific, L.L.C. | Method, computer program, and system for automated real-time signal analysis for detection, quantification, and prediction of signal changes |
US6466822B1 (en) | 2000-04-05 | 2002-10-15 | Neuropace, Inc. | Multimodal neurostimulator and process of using it |
US6826428B1 (en) | 2000-04-11 | 2004-11-30 | The Board Of Regents Of The University Of Texas System | Gastrointestinal electrical stimulation |
DE10018360C2 (en) | 2000-04-13 | 2002-10-10 | Cochlear Ltd | At least partially implantable system for the rehabilitation of a hearing impairment |
US6522928B2 (en) | 2000-04-27 | 2003-02-18 | Advanced Bionics Corporation | Physiologically based adjustment of stimulation parameters to an implantable electronic stimulator to reduce data transmission rate |
US6610713B2 (en) | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
US7485095B2 (en) | 2000-05-30 | 2009-02-03 | Vladimir Shusterman | Measurement and analysis of trends in physiological and/or health data |
DE60018556T2 (en) | 2000-07-11 | 2006-03-02 | Sorin Biomedica Crm S.R.L., Saluggia | Implantable pacemaker with automatic mode switching controlled by sympatho-vagal matching |
US7010351B2 (en) | 2000-07-13 | 2006-03-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7024247B2 (en) | 2001-10-15 | 2006-04-04 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US7236831B2 (en) | 2000-07-13 | 2007-06-26 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7305268B2 (en) | 2000-07-13 | 2007-12-04 | Northstar Neurscience, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US7672730B2 (en) | 2001-03-08 | 2010-03-02 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7146217B2 (en) | 2000-07-13 | 2006-12-05 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US6662053B2 (en) | 2000-08-17 | 2003-12-09 | William N. Borkan | Multichannel stimulator electronics and methods |
US6591138B1 (en) | 2000-08-31 | 2003-07-08 | Neuropace, Inc. | Low frequency neurostimulator for the treatment of neurological disorders |
US6487446B1 (en) | 2000-09-26 | 2002-11-26 | Medtronic, Inc. | Method and system for spinal cord stimulation prior to and during a medical procedure |
US7499742B2 (en) | 2001-09-26 | 2009-03-03 | Cvrx, Inc. | Electrode structures and methods for their use in cardiovascular reflex control |
US6615084B1 (en) | 2000-11-15 | 2003-09-02 | Transneuronix, Inc. | Process for electrostimulation treatment of morbid obesity |
US6832114B1 (en) | 2000-11-21 | 2004-12-14 | Advanced Bionics Corporation | Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes |
US6594524B2 (en) | 2000-12-12 | 2003-07-15 | The Trustees Of The University Of Pennsylvania | Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control |
US6609025B2 (en) | 2001-01-02 | 2003-08-19 | Cyberonics, Inc. | Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation |
US6754536B2 (en) | 2001-01-31 | 2004-06-22 | Medtronic, Inc | Implantable medical device affixed internally within the gastrointestinal tract |
US6775573B2 (en) | 2001-03-01 | 2004-08-10 | Science Medicus Inc. | Electrical method to control autonomic nerve stimulation of gastrointestinal tract |
US7299096B2 (en) | 2001-03-08 | 2007-11-20 | Northstar Neuroscience, Inc. | System and method for treating Parkinson's Disease and other movement disorders |
US6477417B1 (en) | 2001-04-12 | 2002-11-05 | Pacesetter, Inc. | System and method for automatically selecting electrode polarity during sensing and stimulation |
US6907295B2 (en) | 2001-08-31 | 2005-06-14 | Biocontrol Medical Ltd. | Electrode assembly for nerve control |
US6684105B2 (en) | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
US6671555B2 (en) | 2001-04-27 | 2003-12-30 | Medtronic, Inc. | Closed loop neuromodulation for suppression of epileptic activity |
EP1385575A1 (en) | 2001-04-30 | 2004-02-04 | Medtronic, Inc. | Transcutaneous monitor and method of use, using therapeutic output from an implanted medical device |
US6671547B2 (en) | 2001-06-13 | 2003-12-30 | Koninklijke Philips Electronics N.V. | Adaptive analysis method for an electrotherapy device and apparatus |
US6622038B2 (en) | 2001-07-28 | 2003-09-16 | Cyberonics, Inc. | Treatment of movement disorders by near-diaphragmatic nerve stimulation |
US6622047B2 (en) | 2001-07-28 | 2003-09-16 | Cyberonics, Inc. | Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation |
US6622041B2 (en) | 2001-08-21 | 2003-09-16 | Cyberonics, Inc. | Treatment of congestive heart failure and autonomic cardiovascular drive disorders |
US6449512B1 (en) | 2001-08-29 | 2002-09-10 | Birinder R. Boveja | Apparatus and method for treatment of urological disorders using programmerless implantable pulse generator system |
US6760626B1 (en) | 2001-08-29 | 2004-07-06 | Birinder R. Boveja | Apparatus and method for treatment of neurological and neuropsychiatric disorders using programmerless implantable pulse generator system |
US6731979B2 (en) | 2001-08-30 | 2004-05-04 | Biophan Technologies Inc. | Pulse width cardiac pacing apparatus |
US7054686B2 (en) | 2001-08-30 | 2006-05-30 | Biophan Technologies, Inc. | Pulsewidth electrical stimulation |
US20050137480A1 (en) | 2001-10-01 | 2005-06-23 | Eckhard Alt | Remote control of implantable device through medical implant communication service band |
US7904161B2 (en) | 2001-10-22 | 2011-03-08 | Oscor Inc. | Lead adaptor having low resistance conductors and/or encapsulated housing |
US7050856B2 (en) | 2002-01-11 | 2006-05-23 | Medtronic, Inc. | Variation of neural-stimulation parameters |
US6721603B2 (en) | 2002-01-25 | 2004-04-13 | Cyberonics, Inc. | Nerve stimulation as a treatment for pain |
WO2003072186A2 (en) | 2002-02-01 | 2003-09-04 | The Cleveland Clinic Foundation | Neurostimulation for affecting sleep disorders |
AU2003214965A1 (en) | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Method and apparatus for subcutaneously advancing a device between locations |
AU2003208906A1 (en) | 2002-02-01 | 2003-09-02 | The Cleveland Clinic Foundation | Apparatus for facilitating delivery of at least one device to a target site in a body |
US7043305B2 (en) | 2002-03-06 | 2006-05-09 | Cardiac Pacemakers, Inc. | Method and apparatus for establishing context among events and optimizing implanted medical device performance |
AUPS101502A0 (en) | 2002-03-11 | 2002-04-11 | Neopraxis Pty Ltd | Wireless fes system |
US7221981B2 (en) | 2002-03-28 | 2007-05-22 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
JP2005528937A (en) | 2002-04-05 | 2005-09-29 | ホルツナー、オリヴァー | Method and apparatus for electromagnetic correction of brain activity |
EP1356762A1 (en) | 2002-04-22 | 2003-10-29 | UbiCom Gesellschaft für Telekommunikation mbH | Device for remote monitoring of body functions |
AU2003241373A1 (en) | 2002-05-03 | 2003-11-17 | Musc Foundation For Research Development | Method, apparatus and system for determining effects and optimizing parameters of vagus nerve stimulation |
US20050165458A1 (en) | 2002-05-09 | 2005-07-28 | Boveja Birinder R. | Method and system to provide therapy for depression using electroconvulsive therapy(ECT) and pulsed electrical stimulation to vagus nerve(s) |
US20060079936A1 (en) | 2003-05-11 | 2006-04-13 | Boveja Birinder R | Method and system for altering regional cerebral blood flow (rCBF) by providing complex and/or rectangular electrical pulses to vagus nerve(s), to provide therapy for depression and other medical disorders |
US20060009815A1 (en) | 2002-05-09 | 2006-01-12 | Boveja Birinder R | Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s) |
US7277761B2 (en) | 2002-06-12 | 2007-10-02 | Pacesetter, Inc. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US6934580B1 (en) | 2002-07-20 | 2005-08-23 | Flint Hills Scientific, L.L.C. | Stimulation methodologies and apparatus for control of brain states |
US7006859B1 (en) | 2002-07-20 | 2006-02-28 | Flint Hills Scientific, L.L.C. | Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes |
US7020508B2 (en) | 2002-08-22 | 2006-03-28 | Bodymedia, Inc. | Apparatus for detecting human physiological and contextual information |
US7615010B1 (en) | 2002-10-03 | 2009-11-10 | Integrated Sensing Systems, Inc. | System for monitoring the physiologic parameters of patients with congestive heart failure |
US8512252B2 (en) | 2002-10-07 | 2013-08-20 | Integrated Sensing Systems Inc. | Delivery method and system for monitoring cardiovascular pressures |
WO2004032720A2 (en) | 2002-10-11 | 2004-04-22 | Flint Hills Scientific, L.L.C. | Multi-modal system for detection and control of changes in brain state |
US7204833B1 (en) | 2002-10-11 | 2007-04-17 | Flint Hills Scientific Llc | Multi-modal system for detection and control of changes in brain state |
US7933646B2 (en) | 2002-10-15 | 2011-04-26 | Medtronic, Inc. | Clustering of recorded patient neurological activity to determine length of a neurological event |
WO2004036370A2 (en) | 2002-10-15 | 2004-04-29 | Medtronic Inc. | Channel-selective blanking for a medical device system |
US7079977B2 (en) | 2002-10-15 | 2006-07-18 | Medtronic, Inc. | Synchronization and calibration of clocks for a medical device and calibrated clock |
AU2003287162A1 (en) | 2002-10-15 | 2004-05-04 | Medtronic Inc. | Configuring and testing treatment therapy parameters for a medical device system |
US7146211B2 (en) | 2002-10-15 | 2006-12-05 | Medtronic, Inc. | Signal quality monitoring and control for a medical device system |
US7236830B2 (en) | 2002-12-10 | 2007-06-26 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US7302298B2 (en) | 2002-11-27 | 2007-11-27 | Northstar Neuroscience, Inc | Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography |
US6959215B2 (en) | 2002-12-09 | 2005-10-25 | Northstar Neuroscience, Inc. | Methods for treating essential tremor |
US7565199B2 (en) | 2002-12-09 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Methods for treating and/or collecting information regarding neurological disorders, including language disorders |
US8064994B2 (en) | 2003-01-14 | 2011-11-22 | The United States Of America As Represented By The Department Of Veterans Affairs | Cervical vagal stimulation induced weight loss |
US7167750B2 (en) | 2003-02-03 | 2007-01-23 | Enteromedics, Inc. | Obesity treatment with electrically induced vagal down regulation |
AU2004209978B2 (en) | 2003-02-03 | 2009-09-10 | Enteromedics Inc. | Electrode band |
US7162307B2 (en) | 2003-02-11 | 2007-01-09 | Medtronic, Inc. | Channel occupancy in multi-channel medical device communication |
EP1601413B1 (en) | 2003-02-21 | 2006-09-20 | Medtronic, Inc. | Implantable neurostimulator programming with battery longevity indication |
IL154801A0 (en) | 2003-03-06 | 2003-10-31 | Karotix Internat Ltd | Multi-channel and multi-dimensional system and method |
US20050187590A1 (en) | 2003-05-11 | 2005-08-25 | Boveja Birinder R. | Method and system for providing therapy for autism by providing electrical pulses to the vagus nerve(s) |
US7444184B2 (en) | 2003-05-11 | 2008-10-28 | Neuro And Cardial Technologies, Llc | Method and system for providing therapy for bulimia/eating disorders by providing electrical pulses to vagus nerve(s) |
US20060074450A1 (en) | 2003-05-11 | 2006-04-06 | Boveja Birinder R | System for providing electrical pulses to nerve and/or muscle using an implanted stimulator |
US7769465B2 (en) | 2003-06-11 | 2010-08-03 | Matos Jeffrey A | System for cardiac resuscitation |
US8214043B2 (en) | 2006-08-29 | 2012-07-03 | Matos Jeffrey A | Control of a defibrillator and/or pacemaker |
WO2004112894A1 (en) | 2003-06-19 | 2004-12-29 | Advanced Neuromodulation Systems, Inc. | Method of treating depression, mood disorders and anxiety disorders using neuromodulation |
WO2005007120A2 (en) | 2003-07-18 | 2005-01-27 | The Johns Hopkins University | System and method for treating nausea and vomiting by vagus nerve stimulation |
CN1856338B (en) | 2003-07-21 | 2012-11-14 | 超治疗有限公司 | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
CA2534363A1 (en) | 2003-08-01 | 2005-02-10 | Brad Fowler | Apparatus and methods for applying neural stimulation to a patient |
US7252090B2 (en) | 2003-09-15 | 2007-08-07 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using neural network |
US7248923B2 (en) | 2003-11-06 | 2007-07-24 | Cardiac Pacemakers, Inc. | Dual-use sensor for rate responsive pacing and heart sound monitoring |
WO2005053788A1 (en) | 2003-12-01 | 2005-06-16 | Medtronic, Inc. | Method and system for vagal nerve stimulation with multi-site cardiac pacing |
US7115096B2 (en) | 2003-12-24 | 2006-10-03 | Cardiac Pacemakers, Inc. | Third heart sound activity index for heart failure monitoring |
US7783349B2 (en) | 2006-04-10 | 2010-08-24 | Cardiac Pacemakers, Inc. | System and method for closed-loop neural stimulation |
US7107097B2 (en) | 2004-01-14 | 2006-09-12 | Northstar Neuroscience, Inc. | Articulated neural electrode assembly |
US7979137B2 (en) | 2004-02-11 | 2011-07-12 | Ethicon, Inc. | System and method for nerve stimulation |
US20050187593A1 (en) | 2004-02-23 | 2005-08-25 | Medtronic, Inc. | Implantable medical device system with communication link to home appliances |
DE102004014694A1 (en) | 2004-03-25 | 2005-10-27 | Universität Bremen | System and device in a tissue of living organisms implantable device for detecting and influencing electrical bio-activity |
US20050222631A1 (en) | 2004-04-06 | 2005-10-06 | Nirav Dalal | Hierarchical data storage and analysis system for implantable medical devices |
US20050228693A1 (en) | 2004-04-09 | 2005-10-13 | Webb James D | Data exchange web services for medical device systems |
US20050245990A1 (en) | 2004-04-28 | 2005-11-03 | Joseph Roberson | Hearing implant with MEMS inertial sensor and method of use |
CA2564122A1 (en) | 2004-04-28 | 2005-11-10 | Transoma Medical, Inc. | Implantable medical devices and related methods |
WO2005107859A1 (en) | 2004-05-04 | 2005-11-17 | The Cleveland Clinic Foundation | Methods of treating medical conditions by neuromodulation of the cerebellar pathways |
US7697991B2 (en) | 2004-05-04 | 2010-04-13 | The Cleveland Clinic Foundation | Methods of treating neurological conditions by neuromodulation of interhemispheric fibers |
US7725196B2 (en) | 2004-05-04 | 2010-05-25 | The Cleveland Clinic Foundation | Corpus callosum neuromodulation assembly |
EP1595497A1 (en) | 2004-05-05 | 2005-11-16 | Drakeley Consulting Llc | Terminal device and wireless data transmission network |
US20050277872A1 (en) | 2004-05-24 | 2005-12-15 | Colby John E Jr | Apparatus and method for mobile medical services |
US7601115B2 (en) | 2004-05-24 | 2009-10-13 | Neuronetics, Inc. | Seizure therapy method and apparatus |
US20060111644A1 (en) | 2004-05-27 | 2006-05-25 | Children's Medical Center Corporation | Patient-specific seizure onset detection system |
US20050267550A1 (en) | 2004-05-28 | 2005-12-01 | Medtronic Minimed, Inc. | System and method for medical communication device and communication protocol for same |
US7801611B2 (en) | 2004-06-03 | 2010-09-21 | Cardiac Pacemakers, Inc. | System and method for providing communications between a physically secure programmer and an external device using a cellular network |
US7519430B2 (en) | 2004-06-17 | 2009-04-14 | Cardiac Pacemakers, Inc. | Dynamic telemetry encoding for an implantable medical device |
US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
WO2006019822A2 (en) | 2004-07-14 | 2006-02-23 | Arizona Technology Enterprises | Pacemaker for treating physiological system dysfunction |
WO2006012423A1 (en) | 2004-07-20 | 2006-02-02 | Medtronic, Inc. | Therapy programming guidance based on stored programming history |
US20060020491A1 (en) | 2004-07-20 | 2006-01-26 | Medtronic, Inc. | Batch processing method for patient management |
WO2006023686A1 (en) | 2004-08-18 | 2006-03-02 | Medtronic, Inc. | Graphical infusion screen interface for programmable implantable medical device |
DE102004043212A1 (en) | 2004-09-03 | 2006-03-09 | Biotronik Vi Patent Ag | Communication module and method for its operation |
EP1804907A2 (en) | 2004-09-10 | 2007-07-11 | The Cleveland Clinic Foundation | Methods and systems of achieving hemodynamic control through neuromodulation |
CA2481631A1 (en) | 2004-09-15 | 2006-03-15 | Dspfactory Ltd. | Method and system for physiological signal processing |
US20060064133A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | System and method for deriving relative physiologic measurements using an external computing device |
US20060064134A1 (en) | 2004-09-17 | 2006-03-23 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements |
US7340302B1 (en) | 2004-09-27 | 2008-03-04 | Pacesetter, Inc. | Treating sleep apnea in patients using phrenic nerve stimulation |
US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7167755B2 (en) | 2004-10-05 | 2007-01-23 | Cardiac Pacemakers, Inc. | Adaptive software configuration for a medical device |
US8175705B2 (en) | 2004-10-12 | 2012-05-08 | Cardiac Pacemakers, Inc. | System and method for sustained baroreflex stimulation |
US8755885B2 (en) | 2004-10-13 | 2014-06-17 | Medtronic, Inc. | Software configurable medical device platform and associated methods |
US7672733B2 (en) | 2004-10-29 | 2010-03-02 | Medtronic, Inc. | Methods and apparatus for sensing cardiac activity via neurological stimulation therapy system or medical electrical lead |
US8244355B2 (en) | 2004-10-29 | 2012-08-14 | Medtronic, Inc. | Method and apparatus to provide diagnostic index and therapy regulated by subject's autonomic nervous system |
US10201305B2 (en) | 2004-11-02 | 2019-02-12 | Medtronic, Inc. | Apparatus for data retention in an implantable medical device |
US20060106430A1 (en) | 2004-11-12 | 2006-05-18 | Brad Fowler | Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods |
US7565200B2 (en) | 2004-11-12 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US8577471B2 (en) | 2004-11-16 | 2013-11-05 | Cardiola Ltd. | Apparatus and method for the cardio-synchronized stimulation of skeletal or smooth muscles |
US20060122864A1 (en) | 2004-12-02 | 2006-06-08 | Gottesman Janell M | Patient management network |
US8374693B2 (en) | 2004-12-03 | 2013-02-12 | Cardiac Pacemakers, Inc. | Systems and methods for timing-based communication between implantable medical devices |
US8108038B2 (en) | 2004-12-17 | 2012-01-31 | Medtronic, Inc. | System and method for segmenting a cardiac signal based on brain activity |
US8112148B2 (en) | 2004-12-17 | 2012-02-07 | Medtronic, Inc. | System and method for monitoring cardiac signal activity in patients with nervous system disorders |
US8112153B2 (en) | 2004-12-17 | 2012-02-07 | Medtronic, Inc. | System and method for monitoring or treating nervous system disorders |
US8041419B2 (en) | 2004-12-17 | 2011-10-18 | Medtronic, Inc. | System and method for monitoring or treating nervous system disorders |
US8108046B2 (en) | 2004-12-17 | 2012-01-31 | Medtronic, Inc. | System and method for using cardiac events to trigger therapy for treating nervous system disorders |
US8209009B2 (en) | 2004-12-17 | 2012-06-26 | Medtronic, Inc. | System and method for segmenting a cardiac signal based on brain stimulation |
CA2593538C (en) | 2005-01-14 | 2013-01-08 | Edward C. Ii Brainard | Bilateral differential pulse method for measuring brain activity |
DE102005003735B4 (en) | 2005-01-26 | 2008-04-03 | Cerbomed Gmbh | Device for transcutaneous stimulation of a nerve of the human body |
US8600521B2 (en) | 2005-01-27 | 2013-12-03 | Cyberonics, Inc. | Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity |
US20060173493A1 (en) * | 2005-01-28 | 2006-08-03 | Cyberonics, Inc. | Multi-phasic signal for stimulation by an implantable device |
US20060173522A1 (en) | 2005-01-31 | 2006-08-03 | Medtronic, Inc. | Anchoring of a medical device component adjacent a dura of the brain or spinal cord |
CA2599959A1 (en) | 2005-03-01 | 2006-09-08 | Functional Neuroscience Inc. | Method of treating depression, mood disorders and anxiety disorders using neuromodulation |
US7889069B2 (en) | 2005-04-01 | 2011-02-15 | Codman & Shurtleff, Inc. | Wireless patient monitoring system |
US20090048500A1 (en) | 2005-04-20 | 2009-02-19 | Respimetrix, Inc. | Method for using a non-invasive cardiac and respiratory monitoring system |
US7640057B2 (en) | 2005-04-25 | 2009-12-29 | Cardiac Pacemakers, Inc. | Methods of providing neural markers for sensed autonomic nervous system activity |
US20060241725A1 (en) | 2005-04-25 | 2006-10-26 | Imad Libbus | Method and apparatus for simultaneously presenting cardiac and neural signals |
US7561923B2 (en) | 2005-05-09 | 2009-07-14 | Cardiac Pacemakers, Inc. | Method and apparatus for controlling autonomic balance using neural stimulation |
US8391990B2 (en) | 2005-05-18 | 2013-03-05 | Cardiac Pacemakers, Inc. | Modular antitachyarrhythmia therapy system |
CA2609346A1 (en) | 2005-07-28 | 2007-02-15 | The General Hospital Corporation | Electro-optical system, apparatus, and method for ambulatory monitoring |
US20070055320A1 (en) | 2005-09-07 | 2007-03-08 | Northstar Neuroscience, Inc. | Methods for treating temporal lobe epilepsy, associated neurological disorders, and other patient functions |
US20070073346A1 (en) | 2005-09-28 | 2007-03-29 | Giorgio Corbucci | Telemetry of combined endocavitary atrial and ventricular signals |
US8165682B2 (en) | 2005-09-29 | 2012-04-24 | Uchicago Argonne, Llc | Surface acoustic wave probe implant for predicting epileptic seizures |
CN103381284B (en) | 2005-10-14 | 2017-03-01 | 内诺斯蒂姆股份有限公司 | Leadless cardiac pacemaker and system |
US8929991B2 (en) | 2005-10-19 | 2015-01-06 | Advanced Neuromodulation Systems, Inc. | Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits |
US7729773B2 (en) | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US20070088403A1 (en) | 2005-10-19 | 2007-04-19 | Allen Wyler | Methods and systems for establishing parameters for neural stimulation |
US7856264B2 (en) | 2005-10-19 | 2010-12-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for patient interactive neural stimulation and/or chemical substance delivery |
US20070088404A1 (en) | 2005-10-19 | 2007-04-19 | Allen Wyler | Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders |
US8108048B2 (en) | 2005-11-30 | 2012-01-31 | Medtronic, Inc. | Protocol implementation for telemetry communications involving implantable medical devices |
US20090221882A1 (en) | 2005-12-08 | 2009-09-03 | Dan Gur Furman | Implantable Biosensor Assembly and Health Monitoring system and Method including same |
US20070135855A1 (en) | 2005-12-13 | 2007-06-14 | Foshee Phillip D | Patient management device for portably interfacing with a plurality of implantable medical devices and method thereof |
WO2007072425A2 (en) | 2005-12-20 | 2007-06-28 | Koninklijke Philips Electronics, N.V. | Device for detecting and warning of a medical condition |
US8046069B2 (en) | 2005-12-22 | 2011-10-25 | Cardiac Pacemakers, Inc. | Method and apparatus for control of cardiac therapy using non-invasive hemodynamic sensor |
US8868172B2 (en) | 2005-12-28 | 2014-10-21 | Cyberonics, Inc. | Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders |
US9566447B2 (en) | 2005-12-28 | 2017-02-14 | Cardiac Pacemakers, Inc. | Neural stimulation system for reducing atrial proarrhythmia |
US8725243B2 (en) | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
US20070149952A1 (en) | 2005-12-28 | 2007-06-28 | Mike Bland | Systems and methods for characterizing a patient's propensity for a neurological event and for communicating with a pharmacological agent dispenser |
US20070156450A1 (en) | 2006-01-04 | 2007-07-05 | Steven Roehm | Networked modular and remotely configurable system and method of remotely monitoring patient healthcare characteristics |
US8827905B2 (en) | 2006-01-04 | 2014-09-09 | General Electric Company | Patient initiated on-demand remote medical service with integrated knowledge base and computer assisted diagnosing characteristics |
US20080051852A1 (en) | 2006-01-21 | 2008-02-28 | Cerbomed Gmbh | Device and method for the transdermal stimulation of a nerve of the human body |
US7606622B2 (en) | 2006-01-24 | 2009-10-20 | Cardiac Pacemakers, Inc. | Method and device for detecting and treating depression |
US20070287931A1 (en) | 2006-02-14 | 2007-12-13 | Dilorenzo Daniel J | Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
US20070208390A1 (en) | 2006-03-01 | 2007-09-06 | Von Arx Jeffrey A | Implantable wireless sound sensor |
US8209018B2 (en) | 2006-03-10 | 2012-06-26 | Medtronic, Inc. | Probabilistic neurological disorder treatment |
US8615309B2 (en) | 2006-03-29 | 2013-12-24 | Catholic Healthcare West | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US7496409B2 (en) | 2006-03-29 | 2009-02-24 | Medtronic, Inc. | Implantable medical device system and method with signal quality monitoring and response |
US20070239211A1 (en) | 2006-03-31 | 2007-10-11 | Andras Lorincz | Embedded neural prosthesis |
US7949401B2 (en) | 2006-04-11 | 2011-05-24 | Advanced Neuromodulation Systems, Inc. | Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods |
US8926676B2 (en) | 2006-04-11 | 2015-01-06 | Advanced Neuromodulation Systems, Inc. | Systems and methods for applying signals, including contralesional signals, to neural populations |
US20070249956A1 (en) | 2006-04-21 | 2007-10-25 | Medtronic, Inc. | Method and apparatus for detection of nervous system disorders |
US8165683B2 (en) | 2006-04-21 | 2012-04-24 | Medtronic, Inc. | Method and apparatus for detection of nervous system disorders |
US7761145B2 (en) | 2006-04-21 | 2010-07-20 | Medtronic, Inc. | Method and apparatus for detection of nervous system disorders |
US20070249953A1 (en) | 2006-04-21 | 2007-10-25 | Medtronic, Inc. | Method and apparatus for detection of nervous system disorders |
US8155742B2 (en) | 2006-04-25 | 2012-04-10 | Medtronic, Inc. | Remote communication system with availability indicator for an implantable medical device |
US7764988B2 (en) | 2006-04-27 | 2010-07-27 | Medtronic, Inc. | Flexible memory management scheme for loop recording in an implantable device |
US7912537B2 (en) | 2006-04-27 | 2011-03-22 | Medtronic, Inc. | Telemetry-synchronized physiological monitoring and therapy delivery systems |
US7610083B2 (en) | 2006-04-27 | 2009-10-27 | Medtronic, Inc. | Method and system for loop recording with overlapping events |
US7856272B2 (en) | 2006-04-28 | 2010-12-21 | Flint Hills Scientific, L.L.C. | Implantable interface for a medical device system |
US20070255337A1 (en) | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Cardiac monitoring via gastrointestinal stimulator |
NL1031958C2 (en) | 2006-06-07 | 2007-12-10 | Hobo Heeze B V | Personal monitoring system for real-time signaling of epilepsy attacks. |
EP2034885A4 (en) | 2006-06-23 | 2010-12-01 | Neurovista Corp | Minimally invasive monitoring systems and methods |
US20080046038A1 (en) | 2006-06-26 | 2008-02-21 | Hill Gerard J | Local communications network for distributed sensing and therapy in biomedical applications |
US7949404B2 (en) | 2006-06-26 | 2011-05-24 | Medtronic, Inc. | Communications network for distributed sensing and therapy in biomedical applications |
US8170668B2 (en) | 2006-07-14 | 2012-05-01 | Cardiac Pacemakers, Inc. | Baroreflex sensitivity monitoring and trending for tachyarrhythmia detection and therapy |
DE102006033623B4 (en) | 2006-07-18 | 2010-04-08 | Cerbomed Gmbh | System for transcutaneous stimulation of a nerve of the human body |
DE102006036069B4 (en) | 2006-07-18 | 2008-09-04 | Cerbomed Gmbh | Audiological transmission system |
WO2008017055A2 (en) | 2006-08-02 | 2008-02-07 | Northstar Neuroscience, Inc. | Methods for treating neurological disorders, including neuropsychiatric and neuropsychological disorders, and associated systems |
US20080046037A1 (en) | 2006-08-18 | 2008-02-21 | Haubrich Gregory J | Wireless Communication Network for an Implantable Medical Device System |
CA2662917C (en) | 2006-09-08 | 2013-04-16 | Cardiomems, Inc. | Physiological data acquisition and management system for use with an implanted wireless sensor |
US8126529B2 (en) | 2006-09-22 | 2012-02-28 | Advanced Neuromodulation Systems, Inc. | Methods and systems for securing electrode leads |
US20080077028A1 (en) | 2006-09-27 | 2008-03-27 | Biotronic Crm Patent | Personal health monitoring and care system |
US8123668B2 (en) | 2006-09-28 | 2012-02-28 | Bioventrix (A Chf Technologies' Company) | Signal transmitting and lesion excluding heart implants for pacing defibrillating and/or sensing of heart beat |
US20080208291A1 (en) | 2006-10-24 | 2008-08-28 | Northstar Neuroscience, Inc. | Frequency shift keying (fsk) magnetic telemetry for implantable medical devices and associated systems and methods |
US8295934B2 (en) | 2006-11-14 | 2012-10-23 | Neurovista Corporation | Systems and methods of reducing artifact in neurological stimulation systems |
US8096954B2 (en) | 2006-11-29 | 2012-01-17 | Cardiac Pacemakers, Inc. | Adaptive sampling of heart sounds |
US20080139870A1 (en) | 2006-12-12 | 2008-06-12 | Northstar Neuroscience, Inc. | Systems and methods for treating patient hypertonicity |
US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US9913593B2 (en) | 2006-12-27 | 2018-03-13 | Cyberonics, Inc. | Low power device with variable scheduling |
US20080161712A1 (en) | 2006-12-27 | 2008-07-03 | Kent Leyde | Low Power Device With Contingent Scheduling |
EP2124734A2 (en) | 2007-01-25 | 2009-12-02 | NeuroVista Corporation | Methods and systems for measuring a subject's susceptibility to a seizure |
WO2008092119A2 (en) | 2007-01-25 | 2008-07-31 | Neurovista Corporation | Systems and methods for identifying a contra-ictal condition in a subject |
US20080183245A1 (en) | 2007-01-31 | 2008-07-31 | Van Oort Geeske | Telemetry of external physiological sensor data and implantable medical device data to a central processing system |
EP2126791A2 (en) | 2007-02-21 | 2009-12-02 | NeuroVista Corporation | Methods and systems for characterizing and generating a patient-specific seizure advisory system |
US7747551B2 (en) | 2007-02-21 | 2010-06-29 | Neurovista Corporation | Reduction of classification error rates and monitoring system using an artificial class |
US8068918B2 (en) | 2007-03-09 | 2011-11-29 | Enteromedics Inc. | Remote monitoring and control of implantable devices |
US8036736B2 (en) | 2007-03-21 | 2011-10-11 | Neuro Vista Corporation | Implantable systems and methods for identifying a contra-ictal condition in a subject |
US20080249591A1 (en) | 2007-04-06 | 2008-10-09 | Northstar Neuroscience, Inc. | Controllers for implantable medical devices, and associated methods |
US20080255582A1 (en) | 2007-04-11 | 2008-10-16 | Harris John F | Methods and Template Assembly for Implanting an Electrode Array in a Patient |
US20090054795A1 (en) | 2007-08-22 | 2009-02-26 | Misczynski Dale J | Method for generating three standard surface ecg leads derived from three electrodes contained in the mid-horizontal plane of the torso |
-
2008
- 2008-01-25 US US12/020,195 patent/US8260426B2/en active Active
-
2009
- 2009-01-22 WO PCT/US2009/000386 patent/WO2009102393A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070203521A1 (en) * | 2002-03-22 | 2007-08-30 | Leptos Biomedical, Inc. | Nerve stimulation for treatment of obesity, metabolic syndrome, and type 2 diabetes |
WO2007018793A1 (en) * | 2005-07-29 | 2007-02-15 | Cyberonics, Inc. | Medical devices and methods for enhancing intrinsic neural activity |
Also Published As
Publication number | Publication date |
---|---|
US20090192567A1 (en) | 2009-07-30 |
US8260426B2 (en) | 2012-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8260426B2 (en) | Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device | |
EP2254657B1 (en) | Changeable electrode polarity stimulation by an implantable medical device | |
US8204603B2 (en) | Blocking exogenous action potentials by an implantable medical device | |
US9375575B2 (en) | Short duration pre-pulsing to reduce stimulation-evoked side-effetcs | |
US8694118B2 (en) | Variable output ramping for an implantable medical device | |
JP6538149B2 (en) | Enhancement of dorsal horn stimulation using multiple electric fields | |
US7974701B2 (en) | Dosing limitation for an implantable medical device | |
JP5802218B2 (en) | System and method for independently operating multiple neural stimulation channels | |
US20060173493A1 (en) | Multi-phasic signal for stimulation by an implantable device | |
US20130261706A1 (en) | Systems and methods for applying rapid sequential electrode stimulation | |
US20070100377A1 (en) | Providing multiple signal modes for a medical device | |
US20090030493A1 (en) | Ribbon Electrode | |
EP3870270B1 (en) | Signal-based automated deep brain stimulation programming | |
US20130324892A1 (en) | Ultrasonic means and methods for dorsal root ganglion neuromodulation | |
AU2020257261A1 (en) | Methods and systems for neural regulation | |
EP2890449B1 (en) | Contingent cardio-protection for epilepsy patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09711046 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09711046 Country of ref document: EP Kind code of ref document: A1 |